581 results on '"Directorate General of Health Services"'
Search Results
2. Effectiveness Trial of Thermal Jacket
- Author
-
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, Directorate General of Health Services (DGHS), Bangladesh, and Poeticgem International Ltd
- Published
- 2024
3. Low-Cost and Reusable Thermal Jacket for Managing Preterm or Low Birth Weight Neonates.
- Author
-
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, Directorate General of Health Services (DGHS), Bangladesh, Poeticgem International Ltd, and University of Dhaka
- Published
- 2024
4. Introduction of Preconception Care Through Public Health System for Improving MNCH&FP (MNCH&FP)
- Author
-
Directorate General of Family Planning, Minstry of Health and Family Welfare, Bangladesh, Directorate General of Health Services, Minstry of Health and Family Welfare, Bangladesh, UNFPA, and FCDO
- Published
- 2023
5. Community-based HEARTS Intervention (Pilot) (CB-HEARTS)
- Author
-
National Heart Foundation Hospital and Research Institute, Johns Hopkins University, Non-communicable Disease Control Programme, Directorate General of Health Services, Bangladesh, and Community Based Health Care, Directorate General of Health Services, Bangladesh
- Published
- 2023
6. HEARTS Package Evaluation Trial in Bangladesh
- Author
-
Resolve to Save Lives, National Heart Foundation Hospital and Research Institute, Bangladesh, Non-communicable Disease Control Programme, Directorate General of Health Services, Bangladesh, and Johns Hopkins University
- Published
- 2023
7. Reducing Behavioral Risk Factors of NCDs: Protocol for a School-based Health Education Program in Bangladesh
- Author
-
Directorate General of Health Services
- Published
- 2019
8. A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh
- Author
-
Community Based Medical College, Bangladesh, Dhaka Medical College, and Directorate General of Health Services of Bangladesh
- Published
- 2018
9. Replacement of Insecticides to Control Visceral Leishmaniasis (VL)
- Author
-
Rajendra Memorial Research Institute of Medical Sciences, B.P. Koirala Institute of Health Sciences, and Directorate General of Health Services, GoB
- Published
- 2017
10. Introduction of Cholera Vaccine in Bangladesh (ICVB)
- Author
-
Bill and Melinda Gates Foundation, Directorate General of Health Services, Ministry of Health and Family Welfare, Bangladesh, International Vaccine Institute, Dhaka City Corporation, Ministry of Local Government and Rural Development, Bangladesh, School of Public Health and Health Professions, University at Buffalo, USA, Johns Hopkins Bloomberg School of Public Health, and University of Maryland
- Published
- 2017
11. Community-Integrated Management of Childhood Illness (IMCI) Programme Evaluation
- Author
-
Directorate General for Health Services, Ministry of Health, Bangladesh, Johns Hopkins Bloomberg School of Public Health, World Health Organization, and UNICEF
- Published
- 2014
12. Estimation and prediction of doubling time for COVID-19 epidemic in Bangladesh: a study of first 14 month’s daily confirmed new cases and deaths
- Author
-
Haque, Mohammad Farhadul; Shaheed Monsur Ali Medical College & Hospital, Dhaka-1215, Bangladesh, Rahman, Mohammad Meshbahur; Biomedical Research Foundation, Dhaka-1230, Bangladesh. & Department of Basic Science, World University of Bangladesh, Dhaka-1230,Bangladesh., Alif, Sheikh M; Monash University, Melbourne, Victoria, Australia, Akter, Emily; Enam Medical College and Hospital, Dhaka, Bangladesh, Barua, Shomrita; Directorate General of Health Services (DGHS), Mohakhali, Dhaka-1212, Bangladesh, Paul, Gowranga Kumar; Department of Statistics, Mawlana Bhashani Science and Technology University, Santosh, Tangail-1902, Bangladesh., Haider, Najmul; The Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, United Kingdom, Haque, Mohammad Farhadul; Shaheed Monsur Ali Medical College & Hospital, Dhaka-1215, Bangladesh, Rahman, Mohammad Meshbahur; Biomedical Research Foundation, Dhaka-1230, Bangladesh. & Department of Basic Science, World University of Bangladesh, Dhaka-1230,Bangladesh., Alif, Sheikh M; Monash University, Melbourne, Victoria, Australia, Akter, Emily; Enam Medical College and Hospital, Dhaka, Bangladesh, Barua, Shomrita; Directorate General of Health Services (DGHS), Mohakhali, Dhaka-1212, Bangladesh, Paul, Gowranga Kumar; Department of Statistics, Mawlana Bhashani Science and Technology University, Santosh, Tangail-1902, Bangladesh., and Haider, Najmul; The Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, United Kingdom
- Abstract
Background: The doubling time is a reliable indicator to estimate the rate at which the pandemic is spreading. We evaluated and predicted the doubling time for the daily COVID-19 cases and deaths in Bangladesh.Methods: Publicly available daily data on COVID-19 new cases from 8 March, 2020 to 14 February, 2021 and the daily deaths data from 18 March, 2020 to 14 February, 2021 were used to predict doubling time based on records from seven days prior. Then, short-term predictions for the next 14 days (1 to 14 February, 2021) were performed to validate the accuracy of our prediction. Finally, using the doubling time data up to 14 February, 2021, a two months (15 February- 15 April, 2021) prediction was made for both daily new COVID-19 cases and deaths.Results: The median doubling time for daily new COVID-19 cases and deaths were 90.51 and 86.02 days respectively in the entire period. The doubling period for cases was lowest in the second to third week of March, 2020 [ranged 2.33-8.43 days] and longest in the second week of March, 2021 [ranged 834-2187 days]. Our prediction suggests that the doubling time for daily confirmed new COVID-19 case will be 1310.33 days [95% CI: 854.33 - 1766.32] and deaths will be 683.04 days [556.05 - 810.03] on 15 April, 2021 in Bangladesh.Conclusion: Our prediction is based on current testing strategies. Any changes in daily number of tests or sudden changes of the dynamics of COVID-19 transmission would affect these predictions.
- Published
- 2021
13. Are cercarial emergence rhythms of the diurnal and nocturnal chronotypes of the parasite Schistosoma mansoni circadian ?
- Author
-
Lasica, Chrystelle, Mouahid, Gabriel, F., Chevalier, Le Clec’h, Winka, Chaparro, Cristian, Grunau, Christoph, Savassi, Boris A.E.S., Al Yafae, Salem, Anderson, Timothy J., Moné, Hélène, Interactions Hôtes-Pathogènes-Environnements (IHPE), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut Français de Recherche pour l'Exploitation de la Mer (IFREMER)-Université de Perpignan Via Domitia (UPVD), Texas Biomedical Research Institute [San Antonio, TX], Directorate General of Health Services, Dhofar Governorate, and Ministry of Health [Mozambique]
- Subjects
[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE] ,ComputingMilieux_MISCELLANEOUS - Abstract
International audience
- Published
- 2021
14. Genetic analysis of praziquantel response in schistosome parasites implicates a Transient Receptor Potential channel
- Author
-
Aidan M. Emery, Tim J. Anderson, Amadou Garba Djirmay, Amanda Strickland, Frédéric D. Chevalier, Marina McDew-White, Hélène Moné, Robbie Diaz, Khalid M. Al Mashikhi, Bonnie L. Webster, Joanne P. Webster, Ana Mattos, Salem Al Yafae, Claudia M. Rohr, Jonathan S. Marchant, Gabriel Mouahid, Mohamed A. Idris, Safari Kinung’hi, Fiona Allan, David Rollinson, Winka Le Clec’h, Philip T. LoVerde, Texas Biomedical Research Institute [San Antonio, TX], University of Texas Health Science Center at San Antonio [San Antonio], Medical College of Wisconsin [Milwaukee] (MCW), National Institute for Medical Research [Tanzania] (NIMR), The Natural History Museum [London] (NHM), Parasites and Vectors Division, London Centre for Neglected Tropical Disease Research, Natural History Museum, Wolfson Wellcome Biomedical Laboratories, The Natural History Museum, CEEED Centre for Emerging, Endemic and Exotic Diseases, Royal Veterinary College, Réseau International Schistosomiases Environnemental Aménagement et Lutte, World Health Organization [Geneva], Directorate General of Health Services, Sultan Qaboos University (SQU), Interactions Hôtes-Pathogènes-Environnements (IHPE), and Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut Français de Recherche pour l'Exploitation de la Mer (IFREMER)-Université de Perpignan Via Domitia (UPVD)
- Subjects
030231 tropical medicine ,Nonsense mutation ,Population ,Schistosomiasis ,Biology ,Pharmacology ,Genetic analysis ,Praziquantel ,03 medical and health sciences ,Transient receptor potential channel ,Transient Receptor Potential Channels ,0302 clinical medicine ,parasitic diseases ,medicine ,Animals ,Parasites ,Allele ,education ,030304 developmental biology ,Anthelmintics ,0303 health sciences ,education.field_of_study ,[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE] ,General Medicine ,medicine.disease ,biology.organism_classification ,Schistosomiasis mansoni ,3. Good health ,Schistosoma mansoni ,Genome-Wide Association Study ,medicine.drug - Abstract
Mass treatment with praziquantel (PZQ) monotherapy is the mainstay for schistosomiasis treatment. This drug shows imperfect cure rates in the field and parasites showing reduced PZQ response can be selected in the laboratory, but the extent of resistance in Schistosoma mansoni populations is unknown. We examined the genetic basis of variation in PZQ response in a S. mansoni population (SmLE-PZQ-R) selected with PZQ in the laboratory: 35% of these worms survive high dose (73 µg/mL) PZQ treatment. We used genome wide association to map loci underlying PZQ response. The major chr. 3 peak contains a transient receptor potential (Sm.TRPMPZQ) channel (Smp_246790), activated by nanomolar concentrations of PZQ. PZQ response shows recessive inheritance and marker-assisted selection of parasites at a single Sm.TRPMPZQ SNP enriched populations of PZQ-resistant (PZQ-ER) and sensitive (PZQ-ES) parasites showing >377 fold difference in PZQ response. The PZQ-ER parasites survived treatment in rodents better than PZQ-ES. Resistant parasites show 2.25-fold lower expression of Sm.TRPMPZQ than sensitive parasites. Specific chemical blockers of Sm.TRPMPZQ enhanced PZQ resistance, while Sm.TRPMPZQ activators increased sensitivity. A single SNP in Sm.TRPMPZQ differentiated PZQ-ER and PZQ-ES lines, but mutagenesis showed this was not involved in PZQ-response, suggesting linked regulatory changes. We surveyed Sm.TRPMPZQ sequence variation in 259 parasites from the New and Old World revealing one nonsense mutation that results in a truncated protein with no PZQ-binding site. Our results demonstrate that Sm.TRPMPZQ underlies variation in PZQ response in S. mansoni and provides an approach for monitoring emerging PZQ-resistance alleles in schistosome elimination programs.One Sentence SummaryA transient receptor potential channel determines variation in praziquantel-response in Schistosoma mansoni.
- Published
- 2021
- Full Text
- View/download PDF
15. Host-parasite life-histories of the diurnal vs. nocturnal chronotypes of Schistosoma mansoni: adaptive significance
- Author
-
Khalid M. Al Mashikhi, Salem Al Yafae, Rodrigue Mintsa Nguema, Gabriel Mouahid, Mohamed A. Idris, Hélène Moné, Interactions Hôtes-Pathogènes-Environnements (IHPE), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut Français de Recherche pour l'Exploitation de la Mer (IFREMER)-Université de Perpignan Via Domitia (UPVD), Institut de Recherche en Ecologie Tropicale Libreville, Directorate General of Health Services, Department of Microbiology and Immunology, College of Medicine and Health Sciences, and Sultan Qaboos University (SQU)
- Subjects
Male ,circadian rhythm ,nocturnal chronotype ,030231 tropical medicine ,Population ,Zoology ,Snail ,sympatric speciation ,Nocturnal ,Disease Vectors ,Host-Parasite Interactions ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Biomphalaria pfeifferi ,biology.animal ,parasitic diseases ,Animals ,Humans ,[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology ,Cercaria ,education ,Phylogeny ,education.field_of_study ,biology ,Biomphalaria ,Public Health, Environmental and Occupational Health ,Intermediate host ,Chronotype ,Schistosoma mansoni ,biology.organism_classification ,Adaptation, Physiological ,Schistosomiasis mansoni ,3. Good health ,Rats ,Survival Rate ,cercarial emergence pattern ,Infectious Diseases ,Phenotype ,Sympatric speciation ,Parasitology ,Female - Abstract
To optimise host-to-host transmission, digenean trematodes (parasites) synchronise their cercarial emission patterns with the aquatic activities of their vertebrate hosts. Schistosoma mansoni has two different circadian chronotypes: a diurnal shedding pattern with a mean peak occurring at 11:00 h, and a nocturnal shedding pattern with a mean peak occurring at 20:00 h. We analysed the life-history variations between these two chronotypes at the levels of the parasite and its hosts.For each chronotype, we quantified three life-history traits related to the parasite (prepatent period, infection rate and cercarial production) and analysed the morphometry and the morphology of the parasite eggs; we also quantified three life-history traits related to the snail intermediate host (shell diameter, fecundity and survival rate) and one life-history trait related to the experimental definitive host (survival rate). A phylogeny based on the mitochondrial cytochrome-oxidase gene was made on samples of both chronotypes.Life-history analysis revealed significant variations between the two chronotypes. Life-history traits were optimal for both the parasite and the snail host for the diurnal chronotype compared to the nocturnal one. The new chronotype behaved like an allopatric population towards its snail host. Phylogenetic analysis supports the hypothesis of a lateral transfer of S. mansoni from humans to Rattus rattus. These results were interpreted in terms of an ongoing sympatric speciation.The nocturnal chronotype of S. mansoni showed non-adapted life-history traits in its relation with the snail intermediate host Biomphalaria pfeifferi. The emergence of this new phenotype is probably linked to divergent natural selection.Afin d'optimiser la transmission d'hôte à hôte, les trématodes digènes (parasites) synchronisent leurs schémas d’émission cercarienne avec les activités aquatiques de leurs hôtes vertébrés. Schistosoma mansoni a deux chronotypes circadiens différents: un schéma de libérations diurnes avec un pic moyen survenant à 11h00 et un schéma nocturne avec un pic moyen à 20h00. Nous avons analysé les variations de l'histoire de vie entre ces deux chronotypes aux niveaux du parasite et de ses hôtes. MÉTHODES: Pour chaque chronotype, nous avons quantifié trois traits d'histoire de vie liés au parasite (période prépatente, taux d'infection et production cercarienne) et avons analysé la morphométrie et la morphologie des œufs du parasite; nous avons également quantifié trois traits d'histoire de vie liés à l'hôte intermédiaire escargot (diamètre de la coquille, fécondité et taux de survie) et un trait d'histoire de vie lié à l'hôte définitif expérimental (taux de survie). Une phylogénie basée sur le gène mitochondrial de la cytochrome oxydase a été réalisée sur des échantillons des deux chronotypes. RÉSULTATS: L'analyse de l'histoire de vie a révélé des variations significatives entre les deux chronotypes. Les traits d'histoire de vie étaient optimaux à la fois pour le parasite et pour l'hôte escargot pour le chronotype diurne par rapport au chronotype nocturne. Le nouveau chronotype se comportait comme une population allopatrique vis-à-vis de son hôte escargot. L'analyse phylogénétique soutient l'hypothèse d'un transfert latéral de S. mansoni de l'homme à Rattus rattus. Ces résultats ont été interprétés en termes de spéciation sympatrique en cours.Le chronotype nocturne de S. mansoni montre des traits d'histoire de vie non adaptés dans sa relation avec l'hôte intermédiaire escargot, Biomphalaria pfeifferi. L’émergence de ce nouveau phénotype est probablement liée à une sélection naturelle divergente.
- Published
- 2019
- Full Text
- View/download PDF
16. The phylogeny of the genus Indoplanorbis (Gastropoda, Planorbidae) from Africa and the French West Indies
- Author
-
Camille Clerissi, Salem Al Yafae, Jean-François Allienne, Moudachirou Ibikounlé, Hélène Moné, Rodrigue Mintsa Nguema, Gabriel Mouahid, Cristian Chaparro, Interactions Hôtes-Pathogènes-Environnements (IHPE), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut Français de Recherche pour l'Exploitation de la Mer (IFREMER)-Université de Perpignan Via Domitia (UPVD), Directorate General of Health Services, Dhofar Governorate, Ministry of Health [Mozambique], Institut de Recherche en Ecologie Tropicale (IRET), Centre national de la recherche scientifique et technologique (CENAREST), Université d'Abomey-Calavi, and University of Abomey Calavi (UAC)
- Subjects
0301 basic medicine ,Genetic diversity ,Phylogenetic tree ,[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE] ,Zoology ,Biology ,Southeast asian ,03 medical and health sciences ,Phylogenetic diversity ,030104 developmental biology ,Genus ,Phylogenetics ,parasitic diseases ,Genetics ,Animal Science and Zoology ,14. Life underwater ,Internal transcribed spacer ,Clade ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics - Abstract
International audience; Indoplanorbis exustus is a freshwater snail known as the intermediate host of various trematode parasites, including different species of the genus Schistosoma. Although its genetic diversity is well described in Asia, the phylogenetic diversity of strains from Africa and Guadeloupe (French West Indies) and their relationship to Asian and SouthEast Asian strains remain unknown. To tackle this issue, we sampled individuals from Africa and Guadeloupe, and we computed phylogenetic reconstructions using five molecular markers: partial sequences of two mitochondrial genes, cox1 and 16S, and three nuclear markers, ITS1, ITS2 (Internal Transcribed Spacer 1 and 2) and 5.8S. Our results suggest that strains in Africa and Guadeloupe come from Asia and that they all belong to a single clade that is widespread around the globe.
- Published
- 2018
- Full Text
- View/download PDF
17. A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
- Author
-
Benoit Witkowski, Hans-Peter Fuehrer, Garib Das Thakur, Céline Barnadas, Djibrine Djalle, Michael Ramharter, Mindy Leelawong, Wasif Ali-Khan, Harald Noedl, Bouasy Hongvanthong, Mohammad Shafiul-Alam, Hypolite Muhindo-Mavoko, Abdillahi Mohamed Hassan, Judith Straimer, Nimol Khim, Kigbafori D. Silué, Kaknika Loch, Barbara H. Stokes, Maria Dorina Bustos, Laura Berne, Dylan R. Pillai, Ayola A. Adegnika, Lin Hua Tang, Rotha Eam, Saorin Kim, Alioune Dieye, Mei Li, Carole E. Eboumbou-Moukoko, Lydie Canier, Marian Warsame, Didier Menard, David A. Fidock, Yap Boum, Lyndes Wini, Abdiqani Sheikh-Omar, Patrick Tshibangu-Wa-Tshibangu, Maman Laminou Ibrahim, Mohammad Jahirul-Karim, Malen Ken, Monique A. Dorkenoo, Sócrates Herrera, Odile Mercereau-Puijalon, Lise Musset, Valentine Duru, Eric Legrand, Maniphone Khanthavong, Pascal Ringwald, Bruno Pradines, Sandrine Houzé, Rachida Tahar, Olukemi K. Amodu, Johann Beghain, Sandie Menard, Liwang Cui, Colin J. Sutherland, Jun Hu Chen, Kesara Na-Bangchang, Khin Lin, Michael Nambozi, Rithea Leang, Jean Christophe Barale, Milijaona Randrianarivelojosia, Marcus V. G. Lacerda, Sophy Chy, Frédéric Ariey, Jean-Bosco Ouédraogo, Isabelle Morlais, Maria de Fátima Ferreira-da-Cruz, Lubin Jiang, Christophe Rogier, Jun Cao, Peter G. Kremsner, Bui Quang-Phuc, Inès Vigan-Womas, Din Syafruddin, Jetsumon Sattabongkot, Shigeyuki Kano, Abebe A. Fola, Louis Collet, Karamoko Niaré, Thierry Fandeur, Sedigheh Zakeri, Sodiomon B. Sirima, Antoine Berry, Jean Baptiste Mazarati, Fe Espino, Ghulam Rahim-Awab, Chanra Khean, Offianan Andre Toure, Institut Pasteur du Cambodge, Réseau International des Instituts Pasteur (RIIP), Génétique et Génomique des Insectes vecteurs, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Centre de Recherche Médicale de Lambaréné, Albert Schweitzer, Leiden University Medical Center (LUMC), Universiteit Leiden, International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), University of Ibadan, Nangarhar University, Mahidol University [Bangkok], The Walter and Eliza Hall Institute of Medical Research (WEHI), University of Melbourne, Papua New Guinea Institute for Medical Research (PNGIMR), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Mbarara University of Science and Technology [Mbarara] (MUST), Epicentre Ouganda [Mbarara] [Médecins Sans Frontières], Epicentre [Paris] [Médecins Sans Frontières], World Health Organization (WHO), country office for Thailand, Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), JiangSu University, National Institute of Parasitic Diseases, Center for Disease Control, China, Centre Hospitalier de Mayotte, Pennsylvania State University (Penn State), Penn State System, Epidemiology and Disease Control division (EDCD), Ministry of Public Health [Nepal], Institut Pasteur de Dakar, Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD), Institut Pasteur de Bangui, Université de Lomé [Togo], Université de Douala, Centre Pasteur du Cameroun, Research Institute for Tropical Medicine, Centre International de Recherches Médicales de Franceville (CIRMF), Fundação Oswaldo Cruz / Oswaldo Cruz Foundation (FIOCRUZ), University of Gondar, Institute of Parasitology [Vienna], University of Veterinary Medicine, Vienna, World Health Organisation (WHO), country office for Somalia, Caucaseco scientific research center = Centro de Investigación Científica Caucaseco, National Center for Malariology, Parasitology and Entomology, Ministry of Health [Mozambique], Hôpital Bichat - Claude Bernard, Mère et enfant en milieu tropical : pathogènes, système de santé et transition épidémiologique (MERIT - UMR_D 216), Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5), Centre de Recherche Médicale et Sanitaire (Niamey, Niger) (CERMES), Directorate General of Health Services (DGHS), Institut Pasteur de Shanghai, Académie des Sciences de Chine - Chinese Academy of Sciences (IPS-CAS), National Center for Global Health and Medicine [Japan] (NCGM), Institut Pasteur du Laos, Instituto Leônidas e Maria Deane - Fiocruz Amazônia [Manaus, Brésil] (ILMD), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Fundação de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD), National Center for Malaria Control, Parasitology and Entomology, Ministry of Health of Cambodgia, Henry M. Jackson Foundation for the Advancement of Military Medicine (HJM), U.S. Naval Medical Research, The Department of Medical Research (Upper Myanmar), Rwanda Biomedical Center (RBC), Centre de Physiopathologie Toulouse Purpan (CPTP), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche pour le Développement [Yaoundé, Cameroun] (IRD [Cameroun]), Institut de Recherche pour le Développement (IRD), University of Kinshasa (UNIKIN), University of Antwerp (UA), Institut Pasteur de la Guyane, Thammasat University (TU), Tropical Diseases Research Center (TDRC), Université de Bamako, Medizinische Universität Wien = Medical University of Vienna, Institut de Recherche en Sciences de la Santé (IRSS) / Centre Muraz, Medicines for Malaria Venture (MMV), Université de Genève = University of Geneva (UNIGE), Global Malaria Programme, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence du Paludisme, Institut Pasteur de Madagascar, Ministry of Health and Human Services [Somalia], Centre Suisse de Recherches Scientifiques en Cote d'Ivoire [Abidjan] (CSRS-CI), Université Félix Houphouët-Boigny (UFHB), Groupe de recherche action en santé (GRAS), London School of Hygiene and Tropical Medicine (LSHTM), University of Hasanuddin, Eijkman Institute for Molecular Biology [Jakarta], Institut Pasteur de Côte d'Ivoire, Ministry of Health and Medical Services, Institut Pasteur d'Iran, Centre National de Référence du Paludisme [Cayenne, Guyane française] (CNR - laboratoire associé), Microbiologie structurale - Structural Microbiology (Microb. Struc. (UMR_3528 / U-Pasteur_5)), Institut Pasteur [Paris] (IP)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Columbia University Irving Medical Center (CUIMC), Institut de Recherche Biomédicale des Armées [Antenne Marseille] (IRBA), AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Descartes - Paris 5 (UPD5), Supported by the Institut Pasteur Paris, Institut Pasteur International Division, Institut Pasteur Cambodia, and the World Health Organization, by a grant (ANR-10-LABX-62-IBEID) from the French Government Investissement d’Avenir program, Laboratoire d’Excellence 'Integrative Biology of Emerging Infectious Diseases', a grant from Natixis Banques, a grant (R01I109023, to Dr. Fidock) from the National Institutes of Health, grants from the Fiocruz Fundação Oswaldo Cruz, Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro, Fundação de Amparo à Pesquisa do Estado do Amazonas, the Brazilian National Council for Scientific and Technological Development, the Agence Nationale de la Recherche (13-BSV3-0018-01 and11-BSV7-009-01), the Austrian Federal Ministry of Science, Research, and Econo-my, the Calgary Laboratory Services, the Centre International de Recherches Médicales de Franceville, the European and Developing Countries Clinical Trials Partnership (CT-2004-31070-001), the Drugs for Neglected Diseases Initiative, the Else Kroener Fresenius Stiftung, the Holger Poehlmann Stiftung, the European Community African–European Research Initiative 'IDEA' (HEALTH-F3-2009-241642), the Fonds Wetenschappelijk Onderzoek, the Vlaamse Interuniversitaire Raad–Universitaire Ontwikkelingssamenwerking, the Belgian Technical Cooperation in Democratic Republic of Congo, the European Community Seventh Framework Program (FP7/2007-2013, 242095, and 223601), the European Commission (REGPOT-CT-2011-285837-STRONGER), the Ministère de la Santé Publique du Niger (Laboratoire National de Référence Résistance aux Antipaludiques), the Foundation of National Science and Technology Major Program (2012ZX10004-220), the French Ministry of Health (Institut National de Veille Sanitaire), the Global Fund to Fight AIDS, Tuberculosis and Malaria, the 5% Initiative program (French Ministry of Foreign Affairs, France Expertise Internationale, 12INI109), the Institut Pasteur de Madagascar, the Government of the Philippines, the Institut de Recherche pour le Développement, the Foundation des Treilles, the Délégation Générale pour l’Armement (PDH-2-NRBC-4-B1-402), the Institut Pasteur de Bangui, the International Society for Health Research and Training, the Malaria Research Initiative Bandarban, Vienna, International Centre for Diarrhoeal Disease Research, Bangladesh, the Médecins sans Frontières (Centre Opérationnel Paris, France), Medicines for Malaria Venture, the National Research Council of Thailand, the Thammasat University, the National Natural Science Foundation of China (81271870, 81361120405, and 81271863), the Natural Science Foundation of Jiangsu Province (BK20130114 and BK20150001), the Jiangsu Science and Technology Department (BM2015024), the National Institutes of Health (R01 AI11646601, AI109023, and ICEMR U19AI089702, U19AI089672), the Pasteur Institute of Iran, the Malaria Division of the Iranian Center for Diseases Management and Control, Public Health England (Malaria Reference Service Contract), the Government of Rwanda, the U.S. Department of Defense Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System (P0463-14-N6), the Fogarty International Center of the National Institutes of Health training (D43 TW007393), the Mahidol-Oxford Research Unit, the Government of Japan (Science and Technology Agency, Agency for Medical Research and Development, Japan International Cooperation Agency, and Science and Technology Research Partnership for Sustainable Development), and the President’s Malaria Initiative of the U.S. Agency for International Development., The KARMA Consortium, ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), ANR-13-BSV3-0018,MALARTRES,Résistance de Plasmodium aux antipaludiques de la famille des artémisinines(2013), ANR-13-BSV7-0009,NEBEDIV,Le rôle des ennemis naturels dans la diversité béta des arbres tropicaux(2013), European Project: CT-2004-31070-001,EDCCTP, European Project: HEALTH-F3-2009-24164,IDEA, European Project: FP7/2007-2013, 24209,FP7, European Project: FP7/2007-2013, 22360,FP7, European Project: 285837,EC:FP7:REGPOT,FP7-REGPOT-2011-1,STRONGER(2011), European Project: 242095,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,EVIMALAR(2009), European Project: 223601,EC:FP7:HEALTH,FP7-HEALTH-2007-B,MALVECBLOK(2009), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), CHU Toulouse [Toulouse], Fundação Oswaldo Cruz (FIOCRUZ), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Genève (UNIGE), INSB-INSB-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence du Paludisme [Cayenne, Guyane française] (CNR), Université Paris Diderot - Paris 7 (UPD7)-Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Eberhard Karls Universität Tübingen, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Centre International de Recherches Médicales de Franceville, Caucaseco scientific research center, Mère et enfant face aux infections tropicales (MERIT - UMR_D 216), National Center for Global Health and Medicine (NCGM), Instituto Leônidas e Maria Deane (ILMD), Centre de Physiopathologie Toulouse Purpan ex IFR 30 et IFR 150 (CPTP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche pour le Développement [Yaoundé], Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, Eijkman Institute for Molecular Biology, Laboratoire de Parasitologie, Centre National de Référence du Paludisme - Région Antilles-Guyane, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-WHO Collaborating Center for Surveillance of Antimalarial Drug Resistance, Institut Pasteur [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), ANR-10-LABX-62-IBEID,IBEID,Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases'(2010), Van geertruyden, Jean-Pierre, and KARMA Consortium
- Subjects
0301 basic medicine ,Nonsynonymous substitution ,MESH: Sequence Analysis, DNA ,Endemic Diseases ,MESH: Asia, Southeastern ,Drug Resistance ,Protozoan Proteins ,Drug resistance ,MESH: Genotype ,Lactones ,0302 clinical medicine ,Genotype ,Artemisinin ,Malaria, Falciparum ,MESH: Protozoan Proteins ,Asia, Southeastern ,MESH: Plasmodium falciparum ,Genetics ,biology ,MESH: Malaria, Falciparum ,General Medicine ,Artemisinins ,MESH: China ,3. Good health ,MESH: Endemic Diseases ,MESH: Drug Resistance ,Algorithms ,MESH: Lactones ,medicine.drug ,China ,MESH: Mutation ,030231 tropical medicine ,030106 microbiology ,Plasmodium falciparum ,MESH: Algorithms ,03 medical and health sciences ,parasitic diseases ,MESH: Artemisinins ,MESH: Polymorphism, Genetic ,medicine ,Humans ,[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology ,Allele ,Polymorphism, Genetic ,MESH: Humans ,Haplotype ,Sequence Analysis, DNA ,medicine.disease ,biology.organism_classification ,Virology ,Mutation ,Human medicine ,Malaria - Abstract
Comment inK13-Propeller Mutations and Malaria Resistance, http://www.nejm.org/doi/full/10.1056/NEJMe1604520; International audience; BACKGROUND:Recent gains in reducing the global burden of malaria are threatened by the emergence of Plasmodium falciparum resistance to artemisinins. The discovery that mutations in portions of a P. falciparum gene encoding kelch (K13)-propeller domains are the major determinant of resistance has provided opportunities for monitoring such resistance on a global scale.METHODS:We analyzed the K13-propeller sequence polymorphism in 14,037 samples collected in 59 countries in which malaria is endemic. Most of the samples (84.5%) were obtained from patients who were treated at sentinel sites used for nationwide surveillance of antimalarial resistance. We evaluated the emergence and dissemination of mutations by haplotyping neighboring loci.RESULTS:We identified 108 nonsynonymous K13 mutations, which showed marked geographic disparity in their frequency and distribution. In Asia, 36.5% of the K13 mutations were distributed within two areas--one in Cambodia, Vietnam, and Laos and the other in western Thailand, Myanmar, and China--with no overlap. In Africa, we observed a broad array of rare nonsynonymous mutations that were not associated with delayed parasite clearance. The gene-edited Dd2 transgenic line with the A578S mutation, which expresses the most frequently observed African allele, was found to be susceptible to artemisinin in vitro on a ring-stage survival assay.CONCLUSIONS:No evidence of artemisinin resistance was found outside Southeast Asia and China, where resistance-associated K13 mutations were confined. The common African A578S allele was not associated with clinical or in vitro resistance to artemisinin, and many African mutations appear to be neutral. (Funded by Institut Pasteur Paris and others.).
- Published
- 2016
- Full Text
- View/download PDF
18. Cross-national epidemiology of DSM-IV major depressive episode
- Author
-
Evelyn J. Bromet, Jean-Pierre Lépine, Daphna Levinson, Maria Elena Medina Mora, Noboru Iwata, Laura Helena Andrade, Ronald C. Kessler, Jordi Alonso, Nancy A. Sampson, Jagdish Kaur, Maria Carmen Viana, Koen Demyttenaere, Stanislav Kostyuchenko, Mark Anthony Oakley Browne, A. N. Karam, Giovanni de Girolamo, Chiyi Hu, Ron de Graaf, Jose Posada-Villa, Irving Hwang, Herbert Matschinger, David R. Williams, Department of Psychiatry, State University of New York (SUNY), Department & Institute of Psychiatry, Universidade de São Paulo = University of São Paulo (USP), Department of Health Care Policy, Harvard Medical School [Boston] (HMS), Health Services Research Unit, IMIM (Hospital del Mar Research Institute), IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Netherlands Institute of Mental Health and Addiction, University Hospital Gasthuisberg [Leuven], Shenzhen Institute of Mental Health & Shenzhen Kangning Hospital, Department of Clinical Psychology, Hiroshima International University, Department of Psychiatry and Clinical Psychology, Saint George Hospital University Medical Center-Balamand University Medical School, Directorate General of Health Services, Ukrainian Psychiatric Association, Neuropsychopharmacologie des addictions. Vulnérabilité et variabilité expérimentale et clinique (NAVVEC - UM 81 (UMR 8206/ U705)), Université Paris Diderot - Paris 7 (UPD7)-Institut des sciences du Médicament -Toxicologie - Chimie - Environnement (IFR71), Institut de Recherche pour le Développement (IRD)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Research & Planning, Mental Health Services, Ministry of Health [Mozambique], Institute of Social Medicine, Occupational Health and Public Health, Universität Leipzig, National Institute of Psychiatry, Statewide and Clinical Director Dept of Health and Human Services New Town, University of Tasmania [Hobart, Australia] (UTAS), Instituto Colombiano del Sistema Nervioso, Section of Psychiatric Epidemiology, Department of Society, Human Development and Health, Harvard School of Public Health, Universidade de São Paulo (USP), University Hospital Gasthuisberg, Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-Institut des sciences du Médicament -Toxicologie - Chimie - Environnement (IFR71), Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Université Paris Diderot - Paris 7 (UPD7), Universität Leipzig [Leipzig], The State University of New York ( SUNY ), Universidade de São Paulo ( USP ), Harvard Medical School [Boston] ( HMS ), Neuropsychopharmacologie des addictions. Vulnérabilité et variabilité expérimentale et clinique ( NAVVEC (UM 81) ), Université Paris Diderot - Paris 7 ( UPD7 ) -Institut des sciences du Médicament -Toxicologie - Chimie - Environnement ( IFR71 ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL ( ENSCP ) -Centre National de la Recherche Scientifique ( CNRS ) -Institut de Recherche pour le Développement ( IRD ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL ( ENSCP ) -Centre National de la Recherche Scientifique ( CNRS ) -Institut de Recherche pour le Développement ( IRD ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Ministry of Health, University of Leipzig, University of Tasmania, and BMC, Ed.
- Subjects
Male ,Gerontology ,[ SDV.MHEP.PSM ] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health ,[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health ,lcsh:Medicine ,Global Health ,0302 clinical medicine ,Epidemiology ,Prevalence ,Global health ,Major depressive episode ,Depression (differential diagnoses) ,Depressió psiquica -- Epidemiologia ,Medicine(all) ,education.field_of_study ,Depression ,1. No poverty ,General Medicine ,Middle Aged ,CIDI ,3. Good health ,Diagnostic and Statistical Manual of Mental Disorders ,Female ,medicine.symptom ,Research Article ,Adult ,medicine.medical_specialty ,Adolescent ,Population ,Developing country ,Interviews as Topic ,Young Adult ,03 medical and health sciences ,Age Distribution ,Depressió psíquica -- Aspectes socials ,medicine ,Humans ,Sex Distribution ,education ,Developing Countries ,Aged ,business.industry ,Developed Countries ,lcsh:R ,Mental health ,030227 psychiatry ,Socioeconomic Factors ,[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health ,business ,030217 neurology & neurosurgery ,Demography - Abstract
Background: Major depression is one of the leading causes of disability worldwide, yet epidemiologic data are not available for many countries, particularly low- to middle-income countries. In this paper, we present data on the prevalence, impairment and demographic correlates of depression from 18 high and low- to middle-income countries in the World Mental Health Survey Initiative. Methods: Major depressive episodes (MDE) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DMS-IV) were evaluated in face-to-face interviews using the World Health Organization Composite International Diagnostic Interview (CIDI). Data from 18 countries were analyzed in this report (n = 89,037). All countries surveyed representative, population-based samples of adults. Results: The average lifetime and 12-month prevalence estimates of DSM-IV MDE were 14.6% and 5.5% in the ten high-income and 11.1% and 5.9% in the eight low- to middle-income countries. The average age of onset ascertained retrospectively was 25.7 in the high-income and 24.0 in low- to middle-income countries. Functional impairment was associated with recency of MDE. The female: male ratio was about 2:1. In high-income countries, younger age was associated with higher 12-month prevalence; by contrast, in several low- to middle-income countries, older age was associated with greater likelihood of MDE. The strongest demographic correlate in high-income countries was being separated from a partner, and in low- to middle-income countries, was being divorced or widowed. Conclusions: MDE is a significant public-health concern across all regions of the world and is strongly linked to social conditions. Future research is needed to investigate the combination of demographic risk factors that are most strongly associated with MDE in the specific countries included in the WMH. The Brazil Megacity Mental Health Survey is supported by the State of Brazil Research Foundation (FAPESP) Thematic Project Grant 03/00204-3. The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123), the Piedmont Region (Italy), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP) and other local agencies, and by an unrestricted educational grant from GlaxoSmithKline. The Epidemiological Study on Mental Disorders in India was funded jointly by Government of India and WHO. The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-Shogai-023, H14-Tokubetsu-026, H16-Kokoro-013) from the Japan Ministry of Health, Labour and Welfare. The Lebanese National Mental Health Survey (LEBANON) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), Fogarty International, anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from Janssen Cilag, Eli Lilly, GlaxoSmithKline, Roche and Novartis. The Mexican National Comorbidity Survey (M-NCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the PanAmerican Health Organization (PAHO). Te Rau Hinengaro: The New Zealand Mental Health Survey (NZMHS) is supported by the New Zealand Ministry of Health, Alcohol Advisory Council and the Health Research Council. The South Africa Stress and Health Study (SASH) is supported by the USA National Institute of Mental Health (R01-MH059575) and National Institute of Drug Abuse with supplemental funding from the South African Department of Health and the University of Michigan. The Ukraine Comorbid Mental Disorders during Periods of Social Disruption (CMDPSD) study is funded by the USA National Institute of Mental Health (RO1-MH61905). The USA National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trusts
- Published
- 2011
- Full Text
- View/download PDF
19. Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies
- Author
-
Tanabe, Kazuyuki, Zakeri, Sedigheh, Palacpac, Nirianne Marie Q, Afsharpad, Manada, Randrianarivelojosia, Milijaona, Kaneko, Akira, Marma, Aung Swi Prue, Horii, Toshihiro, Mita, Toshihiro, Laboratory of Malariology, Research Institute for Microbial Diseases, Biotechnology Research Center, Institut Pasteur d'Iran, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Department of Molecular Protozoology, Osaka University [Osaka]-Research Institute for Microbial Diseases, Institut Pasteur de Madagascar, Réseau International des Instituts Pasteur (RIIP), Karolinska Institutet [Stockholm], Emerging and Re-emerging Diseases, Communicable Disease Control, Directorate General of Health Services, Department of International Affairs and Tropical Medicine, Tokyo Women's Medical University (TWMU), and This work was supported by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (18073013), from the Japan Society for Promotion of Sciences (18GS03140013, 20390120, 22406012), and from the Ministry of Health, Labor and Welfare (H20-Shinkou-ippan-013).
- Subjects
MESH: Mutation ,MESH: Polymorphism, Single Nucleotide ,[SDV]Life Sciences [q-bio] ,MESH: Anti-Infective Agents ,Plasmodium falciparum ,Protozoan Proteins ,MESH: Haplotypes ,Polymorphism, Single Nucleotide ,Artemisinins ,Sarcoplasmic Reticulum Calcium-Transporting ATPases ,MESH: Sarcoplasmic Reticulum Calcium-Transporting ATPases ,Anti-Infective Agents ,Gene Frequency ,Haplotypes ,Mechanisms of Resistance ,MESH: Artemisinins ,parasitic diseases ,Mutation ,MESH: Gene Frequency ,Animals ,MESH: Animals ,MESH: Protozoan Proteins ,MESH: Plasmodium falciparum - Abstract
International audience; Recent reports on the decline of the efficacy of artemisinin-based combination therapies (ACTs) indicate a serious threat to malaria control. The endoplasmic/sarcoplasmic reticulum Ca(2+)-ATPase ortholog of Plasmodium falciparum (PfSERCA) has been suggested to be the target of artemisinin and its derivatives. It is assumed that continuous artemisinin pressure will affect polymorphism of the PfSERCA gene (serca) if the protein is the target. Here, we investigated the polymorphism of serca in parasite populations unexposed to ACTs to obtain baseline information for the study of potential artemisinin-driven selection of resistant parasites. Analysis of 656 full-length sequences from 13 parasite populations in Africa, Asia, Oceania, and South America revealed 64 single nucleotide polymorphisms (SNPs), of which 43 were newly identified and 38 resulted in amino acid substitutions. No isolates showed L263E and S769N substitutions, which were reportedly associated with artemisinin resistance. Among the four continents, the number of SNPs was highest in Africa. In Africa, Asia, and Oceania, common SNPs, or those with a minor allele frequency of ≥0.05, were less prevalent, with most SNPs noted to be continent specific, whereas in South America, common SNPs were highly prevalent and often shared with those in Africa. Of 50 amino acid haplotypes observed, only one haplotype (3D7 sequence) was seen in all four continents (64%). Forty-eight haplotypes had frequencies of less than 5%, and 40 haplotypes were continent specific. The geographical difference in the diversity and distribution of serca SNPs and haplotypes lays the groundwork for assessing whether some artemisinin resistance-associated mutations and haplotypes are selected by ACTs.
- Published
- 2010
- Full Text
- View/download PDF
20. Influence of pattern of exposure, parasite genetic diversity and sex on the degree of protection against reinfection with Schistosoma mansoni
- Author
-
Hélène Moné, Mohamed A. Idris, Gabriel Mouahid, Jérôme Boissier, Mahmoud A. Shaban, M. Dumont, Parasitologie fonctionnelle et évolutive [2003-2006] (PFE), Centre National de la Recherche Scientifique (CNRS)-Université de Perpignan Via Domitia (UPVD), Department of Microbiology and Immunology, Sultan Qaboos University (SQU)-College of Medicine and Health Sciences [Baylor], Baylor University-Baylor University, Directorate General of Health Services, Dhofar Governorate, and Ministry of Health [Mozambique]
- Subjects
Male ,Genotype ,030231 tropical medicine ,Spleen ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Immunity ,medicine ,Parasite hosting ,Animals ,030304 developmental biology ,Infectivity ,0303 health sciences ,Genetic diversity ,General Veterinary ,biology ,[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE] ,Genetic Variation ,General Medicine ,Schistosoma mansoni ,biology.organism_classification ,Schistosomiasis mansoni ,Infectious Diseases ,medicine.anatomical_structure ,Liver ,Insect Science ,Immunology ,Parasitology ,Female ,Sex ,Trematoda - Abstract
This paper analyzed, experimentally, the influences of pattern of exposure, parasite genetic diversity, and parasite sex on the degree of protection against reinfection with Schistosoma mansoni in the mouse. The results show that, (1) in infections with one male parasite genotype, successive infections induced a significant decrease in the infectivity of the parasite and significant increases in the spleen and liver weights compared to mass infections, (2) successive infections with one male genotype induced a significant decrease in the infectivity of the parasite compared to successive infections with five male genotypes, and (3) genotype infectivities were determined by the order at which they were used in the successive infections. These results are discussed in terms of protective effect and concomitant immunity and provide an ecological explanation of the natural sex-biased dispersal toward the male schistosomes.
- Published
- 2007
- Full Text
- View/download PDF
21. Innovative Approaches in Regulatory Affairs: Leveraging Artificial Intelligence and Machine Learning for Efficient Compliance and Decision-Making.
- Author
-
Ajmal CS, Yerram S, Abishek V, Nizam VPM, Aglave G, Patnam JD, Raghuvanshi RS, and Srivastava S
- Subjects
- Decision Making, Artificial Intelligence legislation & jurisprudence, Drug Industry legislation & jurisprudence, Machine Learning
- Abstract
Artificial Intelligence (AI) and AI-driven technologies are transforming industries across the board, with the pharmaceutical sector emerging as a frontrunner beneficiary. This article explores the growing impact of AI and Machine Learning (ML) within pharmaceutical Regulatory Affairs, particularly in dossier preparation, compilation, documentation, submission, review, and regulatory compliance. By automating time-intensive tasks, these technologies streamline workflows, accelerate result generation, and shorten the product approval timeline. However, despite their immense potential, AI and ML also introduce new challenges. Issues such as AI software validation, data management security and privacy, potential biases, ethical concerns, and change management requirements must be addressed. This review highlights current AI-based tools actively used by regulatory professionals such as DocShifter, Veeva Vault, RiskWatch, Freyr SubmitPro, Litera Microsystems, cortical.io etc., examines both the benefits and obstacles of integrating these advanced systems into regulatory practices. Given the rapid pace of technological innovation, the article underscores the need for proactive collaboration with regulatory bodies to manage these developments. It also stresses the importance of adapting to evolving regulatory frameworks and embracing new technologies. Although regulatory agencies like the United Sates Food and Drug Administration (USFDA), European Medicines Agency (EMA), and Medicines and Healthcare products Regulatory Agency (MHRA) are working on guidelines for AI and ML adoption, clear, standardized protocols are still in the works. While the journey ahead may be complex, the integration of AI promises to fundamentally reshape regulatory processes and accelerate the approval of safe, effective pharmaceutical products., Competing Interests: Declarations. Conflict of Interest: The authors declare that they have no conflict of interest., (© 2024. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.)
- Published
- 2025
- Full Text
- View/download PDF
22. Health literacy among the rural Bangladeshi population on first aid measures and prevention of snakebite.
- Author
-
Farheen C, Rahman AKMF, Ghose A, Amin MR, Rahman ASMM, Sayeed AA, Rahaman FMA, Howlader C, Khan S, Rashid R, Chowdhury N, Debi GR, Rahman MS, and Faiz MA
- Abstract
Background: Bangladesh has a high rate of snakebite. In rural areas, there is a significant mortality and morbidity rate due to lack of awareness and inappropriate first aid practices. This study aims to determine the knowledge and practices of the rural population in two subdistricts of Bangladesh regarding snakebite prevention and first aid measures., Methods: This cross-sectional survey is part of an intervention study that was carried out in 250 randomly selected primary sampling units of Shibganj in the Chapainawabganj district and Kalapara in the Patuakhali district of Bangladesh. We enrolled a total of 2954 participants. The practice and knowledge were regarded adequate when the score exceeded 50%. We conducted a binomial logistic regression to identify the factors associated with inadequate knowledge and practice., Results: The community's knowledge (15.9%) and practice (14.5%) regarding snakebite prevention was insufficient. More than 77% and 45.4% of respondents believed that applying a tourniquet above the bite site and seeking a traditional healer after a snakebite were effective first aid measures. Poor knowledge was more likely to occur in farming, fishing, homemaker groups and those with lower incomes (11 000-24 000 Bangladeshi taka). Negative practices were associated with females and high family income., Conclusions: This study highlights the necessity of community intervention, with a focus on appropriate first aid and prevention measures through widespread education., (© The Author(s) 2024. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.)
- Published
- 2025
- Full Text
- View/download PDF
23. Expedited pathway insights: Unveiling oncology and non-oncology drug approvals and withdrawals of USFDA and EMA.
- Author
-
Chaugule PD, Varpe PC, Tandulje AA, Raghuvanshi RS, and Srivastava S
- Subjects
- Humans, United States, Europe, Neoplasms drug therapy, Drug Approval, Antineoplastic Agents therapeutic use, United States Food and Drug Administration
- Abstract
Background: Prior to entering the market, health authorities conduct a rigorous evaluation of compiled information for drugs delaying its entry. To address this void expedited pathways are introduced., Methods: In this study, both oncology and non-oncology drugs approved through various expedited pathways from the US and Europe have been scrutinized using the USFDA's Novel Drug approvals from 2020 to 2023 and EMA's Human Medicine Highlights 2020 to 2023. Withdrawals if any along with factors causing withdrawal have also been studied., Results: Among all the pathways accelerated approval has high oncological drug approvals and also high withdrawal for drugs approved based on surrogate endpoints. From the study conducted it was observed that intensive evaluation has to be performed both pre and post-approval for drugs approved based on surrogate endpoints as well as on the conduct of their confirmatory trials., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
24. Brain Abscess: A Comparison of Surgical Outcomes between Conventional Burr Hole Aspiration and Endoscope-Assisted Evacuation.
- Author
-
Ahmed MF, Rana S, Zahan KFI, Munira S, Islam MS, Haque M, Pahwa B, Aydin L, Umana GE, and Chaurasia B
- Subjects
- Humans, Male, Female, Treatment Outcome, Adolescent, Young Adult, Child, Adult, Neuroendoscopy methods, Suction methods, Drainage methods, Child, Preschool, Brain Abscess surgery
- Abstract
Background: Brain abscesses are a major health problem with significant morbidity and mortality rates. The objective of this study was to compare the surgical efficacy of endoscope-assisted evacuation of a brain abscess with that of single burr hole aspiration in a tertiary health care center., Methods: This single-center nonrandomized clinical study was conducted during the period from July 2020 to December 2021. Male and female patients younger than 30 years who presented with brain abscess were enrolled in this study. They were divided into two groups and treated with two different techniques: conventional burr hole aspiration group and endoscope-assisted evacuation group., Results: Thirty patients were enrolled in this study. The mean age was 13.0 ± 6.3 years in the burr hole group and 13.1 ± 6.4 years in the endoscope-assisted group. There was ≥75.0% evacuation of brain abscess on postoperative day 1 in 13 (92.9%) patients in the endoscope-assisted group and in 5 (33.3%) patients in the burr hole group. The mortality rate was 6.7% in both groups. The mean residual volume on postoperative day 30 was 0.75 mL in the endoscope-assisted group and 1.75 mL in the burr hole aspiration group. No patients treated with endoscope-assisted evacuation required a repeat surgery, whereas five patients (33.3%) treated with the conventional burr hole method required a repeat surgery., Conclusions: This study showed that the endoscope-assisted procedure has a better rate of abscess evacuation, lower residual risk, and less chance of repeat surgeries than the conventional burr hole procedure., Competing Interests: None declared., (Thieme. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
25. The cost of COVID-19 vaccine delivery in Bangladesh.
- Author
-
Yesmin A, Moi F, Hossain T, Archer RA, Islam M, and Boonstoppel L
- Subjects
- Humans, Bangladesh epidemiology, SARS-CoV-2 immunology, Vaccination economics, Health Care Costs statistics & numerical data, COVID-19 Vaccines economics, COVID-19 Vaccines administration & dosage, COVID-19 prevention & control, COVID-19 economics, COVID-19 epidemiology, Immunization Programs economics
- Abstract
COVID-19 vaccination has been instrumental in fighting the pandemic, but evidence on the actual costs associated with delivering these vaccines in resource-constrained settings has been limited. We estimated the cost of delivering COVID-19 vaccines in Bangladesh through five delivery strategies in 2021 and 2022, including Ministry of Health (MOH) hospitals, non-MOH government hospitals, outreach at Expanded Program on Immunization (EPI) centers, mass campaigns, and schools. This was a bottom-up costing study, estimating costs from a payer and beneficiary perspective. We also mapped the funding flows for COVID-19 vaccination activities and analyzed programmatic and financial challenges. The economic cost incurred by the health system to deliver COVID-19 vaccines was $1.05 per dose, excluding vaccine costs. This was made up of a financial cost of $0.29 per dose and an opportunity cost of $0.75 per dose. School-based delivery incurred the lowest financial cost of $0.27, while outreach at EPI centers incurred the highest at $0.44 per dose. The low financial cost per dose is attributed to the high daily volumes delivered at sampled sites, minimal additional resources provided to sites to implement the COVID-19 vaccination program, and a reliance on the existing workforce. Beneficiaries spent an average of $1.63 to receive a single dose of COVID-19 vaccination at fixed sites, with transport representing the largest cost driver ($0.75 per dose). The economic cost to receive one dose of the COVID-19 vaccine was $4.78. Findings can support the Government of Bangladesh to make efficient and equitable resource allocation decisions for vaccination programs.
- Published
- 2024
- Full Text
- View/download PDF
26. The next frontier in multiple sclerosis therapies: Current advances and evolving targets.
- Author
-
Sastri KT, Gupta NV, Kannan A, Dutta S, Ali M Osmani R, V B, Ramkishan A, and S S
- Subjects
- Humans, Animals, Molecular Targeted Therapy methods, Biomarkers metabolism, Multiple Sclerosis drug therapy, Multiple Sclerosis therapy, Multiple Sclerosis immunology
- Abstract
Recent advancements in research have significantly enhanced our comprehension of the intricate immune components that contribute to multiple sclerosis (MS) pathogenesis. By conducting an in-depth analysis of complex molecular interactions involved in the immunological cascade of the disease, researchers have successfully identified novel therapeutic targets, leading to the development of innovative therapies. Leveraging pioneering technologies in proteomics, genomics, and the assessment of environmental factors has expedited our understanding of the vulnerability and impact of these factors on the progression of MS. Furthermore, these advances have facilitated the detection of significant biomarkers for evaluating disease activity. By integrating these findings, researchers can design novel molecules to identify new targets, paving the way for improved treatments and enhanced patient care. Our review presents recent discoveries regarding the pathogenesis of MS, highlights their genetic implications, and proposes an insightful approach for engaging with newer therapeutic targets in effectively managing this debilitating condition., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
27. Prevalence and genotypic distribution of high-risk human papillomavirus (HPV) among ever-married women in coastal regions of Bangladesh.
- Author
-
Chakraborty S, Nessa A, Ferdous NE, Rahman MM, Rashid MHU, Sonia AA, and Islam MF
- Subjects
- Humans, Female, Bangladesh epidemiology, Adult, Middle Aged, Prevalence, Cross-Sectional Studies, Uterine Cervical Neoplasms virology, Uterine Cervical Neoplasms epidemiology, DNA, Viral genetics, Human Papillomavirus Viruses, Papillomavirus Infections epidemiology, Papillomavirus Infections virology, Genotype, Papillomaviridae genetics, Papillomaviridae classification, Papillomaviridae isolation & purification
- Abstract
Background: Understanding the distribution of type specific human papillomavirus (HPV) genotypes in screen-detected lesions is crucial to differentiate women who are at a higher risk of developing cervical cancer. This study aimed to find out high-risk HPV genotype distribution among women of the coastal districts of Bangladesh., Methods: This cross-sectional study conducted from January 2023 to December 2023 aimed to investigate the prevalence and distribution patterns of high-risk HPV genotypes among ever-married women aged 30-60 years residing in three coastal districts of Bangladesh. Sampling was purposive, with 300 participants per district. Exclusion criteria included prior cervical precancer or cancer treatment, hysterectomy, cervical amputation, and pregnancy. HPV DNA specimens were collected and tested using Cobas 4800. Positive cases underwent further genotype analysis with GenoFlowTM HPV Array Test Kit. Statistical analysis utilized SPSS version 25.0, employing Chi-square and Fisher's Exact tests., Results: Among 900 participants HR-HPV prevalence was 2.56%. HPV 16 was the most prevalent genotype (38.46%), followed by HPV 66 and HPV 68 (11.54% each). Single infections of HPV 16 predominated (39.13%), while for co-infections HPV 66 and HPV 68 were most common (13.04%). HR-HPV positivity increased with age, peaking at 5.5% in the 55-60 years' age group. Participants education level, occupation, income, and reproductive history showed no significant association with HPV positivity. District-wise prevalence varied insignificantly, with Jhalokathi exhibiting the highest (3.0%), followed by Cox's Bazar (2.7%), and Bagerhat (2.0%). HPV 16 was the predominant genotype across districts, with Cox's Bazar and Jhalokathi demonstrating greater genotype diversity than Bagerhat., Conclusion: The study concludes that among ever-married women in the coastal districts of Bangladesh, there is a low prevalence of high-risk HPV. The predominant high-risk HPV genotypes identified were HPV 16, followed by HPV 66 and 68. These findings hold significant implications for policy makers, providing guidance for targeted screening strategies and vaccination programs., Competing Interests: NO authors have competing interests., (Copyright: © 2024 Chakraborty et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
28. Effectiveness of a package of community-based mental healthcare services to address perinatal mental disorders in Bangladesh: A cluster-randomized controlled trial.
- Author
-
Dutta GK, Ahmed HU, Talukder MQ, Bhattacharyya DS, Reza MS, Rahman MM, Majumdar R, Tofail F, Perry HB, and Biswas TK
- Subjects
- Humans, Bangladesh, Female, Adult, Pregnancy, Young Adult, Outcome Assessment, Health Care, Perinatal Care methods, Anxiety therapy, Community Mental Health Services methods, Stress, Psychological therapy, Depression therapy, Pregnancy Complications therapy
- Abstract
Background: Perinatal mental disorders of women have an impact on their pregnancy and their child's brain development across low and middle-income countries. However, to address this issue, there are no specific guidelines for community-level service providers in Bangladesh. Therefore, we aimed to develop a community-based mental healthcare (CBMHC) service package and test its effectiveness in reducing depression, anxiety, and stress among mothers during the perinatal period., Methods: A cluster-randomized controlled trial (cRCT) was applied to test the CBMHC package in 2017 and 2018. It was provided to one group of mothers along with routine maternal care while another group received only routine maternal care. Paired sample t-test was applied to assess mean changes at baseline and endline in the Depression, Anxiety, and Stress Scales-21 (DASS-21) and EuroQol-5 Dimension and 3 Level (EQ5D3L) scales. A linear mixed-effects model was used to assess the relationship between the DASS-21 score and EQ5D3L., Results: 1215 participants were enrolled, including 605 in the intervention group and 610 in the control group. Measures of depression, anxiety, and stress were significantly decreased in both groups. Reduction in the levels of stress, as measured by changes in the stress score, were significantly greater in the intervention than in the control group (diff: 1.2, 95 % CI: 0.1, 2.2). The EQ5D3L index improved significantly, 0.02 units more at endline in the intervention group than in the control group (diff: 0.02, 95 % CI: 0.007, 0.03). The levels of mobility, usual activities, pain or discomfort, depression, and anxiety improved by 1.4 %, 7.6 %, 4.4 %, 2.6 %, and 0.4 % more, respectively, in the intervention group compared to the control groups. These improvements were statistically significant. The DASS-21 score was negatively and significantly correlated with both the EQ-5D3L index and the Visual Analogue Scale (VAS) score for the intervention group as well as for the usual care group, indicating that EQ5D3L improved when common mental disorders decreased., Conclusion: Although the improvements were modest, a CBMHC service package was effective in reducing perinatal levels of stress among Bangladeshi rural women., Trial Registration: ClinicalTrials.gov ID: NCT03678415., Competing Interests: Declaration of Competing Interest The authors declare there are no competing interests., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
29. Tracing the Trajectory of Aedes aegypti and Aedes albopictus Research: Eight Decades of Bibliometric Retrospect.
- Author
-
Sindhania A, Baruah K, Katewa A, and Sharma YP
- Abstract
Background: The global burden of mosquito-borne diseases transmitted by Aedes aegypti and Aedes albopictus mosquitoes has become a pressing public health concern. This study sought to quantify and evaluate about eight decades of publication data on the global epidemiological trend of the diseases transmitted by A. aegypti and A. albopictus . Methods: A comprehensive bibliographic review of literature was performed on A. aegypti and A. albopictus transmitted diseases, focusing on disease transmission, epidemiological trends, vector control strategies, surveillance and monitoring, and international collaborations and initiatives. Extensive data were collected from the Web of Science database and analyzed for citation network analysis (CNA) using VoSviewer software. Data were collected from the Web of Science database encompassing various aspects of Aedes -borne diseases. The bibliographic CNA was performed to quantify and analyze the 77 years of data on A. aegypti and A. albopictus transmitted diseases. Results: The analysis included 4149 publications contributed by 13,416 authors from 149 countries. These articles comprised research articles (91.01%), review articles (6.267%), proceeding papers (1.76%), and book chapters (0.92%). The results revealed a cumulative h-index of 134, indicating the impact of the scientific output in this field. Conclusion: This review contributes to the ongoing efforts to mitigate the impact of Aedes -borne diseases and protect public health worldwide. By synthesizing current knowledge and evidence-based practices, the study provides all information related to publications, citations, co-citations, top journal trends, high-impact publications, and collaborations among authors in one place among the data published in the past eight decades on Aedes -borne diseases.
- Published
- 2024
- Full Text
- View/download PDF
30. Ophthalmological changes in children with advanced stage of chronic kidney disease: a hospital-based study.
- Author
-
Datta AK, Begum A, Roy RR, Jesmin T, Al Mamun A, Mahfuzullah MA, Chowdhury F, and Iktidar MA
- Subjects
- Humans, Child, Male, Female, Cross-Sectional Studies, Adolescent, Child, Preschool, Eye Diseases epidemiology, Eye Diseases etiology, Renal Dialysis adverse effects, Visual Acuity physiology, Renal Insufficiency, Chronic epidemiology, Renal Insufficiency, Chronic therapy
- Abstract
Background: Ocular disorders can arise in the advanced stages of chronic kidney disease (CKD) for various reasons, including uraemia, biochemical abnormalities, hypertension and inadequate haemodialysis treatment., Methods: We conducted a cross-sectional study at the Pediatric Nephrology Department, both inpatient and outpatient, of from January 2020 to July 2021. The study aimed to identify and compare ophthalmological changes among children at different stages of CKD to assess potential visual threats. A total of 92 children with advanced-stage CKD, aged 5-18 years, meeting the inclusion and exclusion criteria, were included in the study. Comprehensive assessments, including medical history, physical examinations, relevant tests and detailed ophthalmological examinations, were conducted., Results: The mean age of the participants was 12.1±3.68 years. Most of the children were boys (66%). Twenty-nine patients exhibited impaired visual acuity, children with (6/60-6/24) scores in Snellen's chart Lid oedema and conjunctival pallor were observed in 20.7% and 60.9% of cases, respectively, which were found to statistically significant with advancing CKD stages (p<0.001). Dry eyes were found in 9.8% of CKD stage V patients receiving dialysis (VD) (p=0.003). One patient had a posterior subcapsular cataract, and 7.6% had conjunctival congestion. Patients with conjunctival congestion and hypertensive retinopathy had significantly higher levels of serum phosphate and calcium phosphate product (p<0.001). Hypertensive retinopathy was present in 16.3% of cases, with a significantly higher proportion in the haemodialysis group (93%). Haemodialysis patients exhibited higher blood pressure, lower haemoglobin levels, and a more severe reduction in estimated glomerular filtration rate (p<0.001)., Conclusion: This study highlights the significant ocular complications associated with CKD, underscoring the need for regular ophthalmological screenings., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
31. The Rising Threat of Mucormycosis: Oman's Experience Before and During the COVID-19 Pandemic.
- Author
-
Al-Jardani A, Al-Wahaibi A, Al Rashdi A, Spruijtenburg B, AlBulushi N, Rani RS, AlKindi H, Al-Yaquobi F, Al-Rawahi B, AlBalushi A, Al Azri S, Meis JF, AlBuloshi I, Al-Abri S, Al-Harrasi A, Al-Hatmi AMS, and Al Maani A
- Abstract
Mucormycosis is a rare, severe fungal infection mainly affecting immunocompromised individuals. Because of limited data on its epidemiology in Oman, we present this national, multicentric, retrospective review that includes all cases of proven mucormycosis between 2006 and 2022 in Oman. There were 51 cases of mucormycosis reported in Oman. The annual incidence of mucormycosis was 0.38-0.69 cases per million population before COVID-19. During the pandemic, the incidence rose significantly to 1.76 in 2020, 5.31 in 2021, then decreased to 0.87 per million population in 2022. Diabetes was observed in 82.4% ( n = 42) of the cases, COVID-19 in 47.1% ( n = 24), and other chronic diseases in 72.6%. The use of steroids was reported in 33.3% ( n = 17) and many patients (64.7%, n = 33) had multiple risk factors. The overall mortality rate was 41.2% ( n = 21) and most deaths occurred within a month of diagnosis. Mortality rate among patients diagnosed with COVID-19 was 58.3% (14/24). Survival analysis showed a statistically significant association between COVID-19 status and patient survival ( p = 0.024). Annual incidence of mucormycosis in Oman rose during the pandemic. This study highlights the epidemiological features of mucormycosis and emphasizes the importance of its inclusion in the national notifiable communicable diseases priority list as well as the importance of enhancing diagnostic capacities to detect and improve patient outcomes.
- Published
- 2024
- Full Text
- View/download PDF
32. Investigating emergency rescue readiness on Indian national highways: A case study of Jaipur-Jodhpur Highways (India) using a geospatial approach.
- Author
-
Dandabathula G, Roy S, Ghosh K, Chadha I, Rathore S, Kumar G, Joshi NK, Bhardwaj P, Bera AK, Srivastav SK, and Raikwar M
- Abstract
Background: Highways represent the most significant capital asset that any country's public sector holds. A system of national highways with easy access to ambulance and trauma centers is termed emergency rescue ready and helps reduce the mortality due to road accidents. Given the rich impetus for road infrastructure development by the government of India, there is a need to consider emergency rescue readiness on highways. Previous research suggests that on typical Indian highways, an ambulance can reach the accident scene within 30 minutes; the remaining 30 minutes of golden hour is essential for saving the life of the injured by admitting to a healthcare facility with a trauma unit., Objective: To investigate the emergency rescue readiness for a stretch of highway between two cities in India. The main objective is to determine the possibility of transporting the injured due to the accident on the highway to the nearest available trauma center within 30 minutes., Methods: A Geographic Information System (GIS)-based network analysis method has been adopted to find the possibility of transporting the injured anywhere on the circuit of a national highway to the nearest healthcare unit within 30 minutes., Results: A map representing the status of emergency rescue readiness has been presented for the study area. For a circuit of national highway with a length of 805 km, in a stretch of 89.5% (718.5 km), the injured can be transported to the healthcare unit within 30 minutes. In the remaining 10.5% of the highway, the healthcare units are significantly far from the highways and may hamper the post-crash rescue operations., Conclusion: There exists a wide disparity in trauma care delivery in the study area. Currently, the healthcare units established to serve the areas with dense populations also serve as emergency rescues during accidents on the national highways. Using GIS techniques for highway stretches with difficulty reaching the trauma centers, a national-level assessment is highly recommended., Competing Interests: There are no conflicts of interest., (Copyright: © 2024 Journal of Family Medicine and Primary Care.)
- Published
- 2024
- Full Text
- View/download PDF
33. Burden and challenges in managing TB infection among people with occupational exposure to silica in India.
- Author
-
Kalottee B, Mahajan P, Nuken A, Nair D, Thekkur P, Kumar AMV, Rai V, Parmar M, Solanki H, Rao R, Mattoo SK, and Kumar R
- Abstract
Background: Occupational exposure to silica increases the risk of TB infection (TBI) and disease. This study aimed to determine the prevalence of TBI and explore challenges in TBI management in such individuals in two districts of India during 2023., Methods: This was an explanatory mixed-methods study with a quantitative cohort design and qualitative descriptive in-depth interviews., Results: Among 1,555 individuals with occupational exposure to silica, 593 (38%, 95% CI 36-41) underwent interferon-gamma release assay (IGRA) for TBI, of whom 255 (43%, 95% CI 39-47) were found IGRA-positive. Males with occupational silica exposure for ≥20 years had a significantly higher risk of TBI. Of these 160 individuals eligible for TB preventive therapy (TPT), 153 (96%, 95% CI 92-98) were initiated on TPT and 124 (81%, 95% CI 74-88) completed TPT. The low uptake of IGRA was attributed to the stigma associated with TB and reluctance to undergo any medical evaluation., Conclusions: Compared to the general population, individuals with occupational exposure to silica have an almost two times higher prevalence of TBI. Further research is required to identify the threshold of silica exposure to be considered for screening for TBI. Efforts to increase awareness and decrease stigma can improve the uptake of testing for TBI and TB disease., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
34. Text messaging to improve retention in hypertension care in Bangladesh.
- Author
-
Jubayer S, Akhtar J, Abrar AK, Sayem MNN, Islam S, Amin KE, Nahid MF, Bhuiyan MR, Al Mamun MA, Alim A, Amin MR, Burka D, Gupta P, Zhao D, Matsushita K, Moran AE, Choudhury SR, and Gupta R
- Subjects
- Humans, Bangladesh, Female, Male, Middle Aged, Adult, Aged, Patient Compliance, Primary Health Care, Text Messaging, Hypertension therapy, Hypertension diagnosis, Reminder Systems
- Abstract
Visit non-attendance is a common barrier to hypertension control in low and middle-income countries (LMICs). We aimed to evaluate the effectiveness of mobile text messaging in improving visit attendance among patients with hypertension in primary healthcare facilities in Bangladesh. A randomized A/B testing study was conducted with two patient groups: (1) patients regularly attending visits (regular patients) and (2) patients overdue for their follow-up clinic visit (overdue patients). Regular patients were randomized into three groups: a cascade of three text reminders, a single text reminder, or no text reminder. Overdue patients were randomized into two groups: a single text reminder or no text reminder. 20,072 regular patients and 12,708 overdue patients were enrolled. Among regular patients, visit attendance was significantly higher in the cascade reminder group and the single reminder group compared to the no reminder group (78.2% and 76.6% vs. 74.8%, p < 0.001 and 0.027, respectively). Among overdue patients, the single reminder group had a 5.8% higher visit attendance compared to the no reminder group (26.5% vs. 20.7%, p < 0.001). The results remained consistent in multivariable analysis; adjusted prevalence ratio (PR) was 1.04 (95% CI 1.02-1.06) for the cascade reminder group and 1.02 (95% CI 1.00-1.05) for the single reminder group among regular patients. The adjusted PR for the single reminder group vs. the no reminder group among overdue patients was 1.23 (95% CI 1.15-1.33). Text message reminders are an effective strategy for improving retention of patients in hypertension treatment in LMICs, especially for patients overdue to care., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
35. Assessing the role of the for-profit private healthcare sector in malaria elimination efforts in Bangladesh: a cross-sectional study of challenges and opportunities.
- Author
-
Alam MS, Alam MJ, Hossain MS, Matin MA, Phru CS, Hasan A, Rahman MM, Rahaman MM, Islam MN, Das SK, Aktaruzzaman MM, Adnan SD, Islam MN, and Hazarika A
- Subjects
- Humans, Cross-Sectional Studies, Bangladesh epidemiology, Male, Female, Surveys and Questionnaires, Disease Eradication, Adult, Focus Groups, Middle Aged, Malaria prevention & control, Malaria epidemiology, Private Sector
- Abstract
Background: Among 13 endemic districts, the Chittagong Hill Tracts bear more than 90% of Bangladesh's malaria burden. Despite the private sector's prominence in rural healthcare, its role in malaria management remains underutilized. This study aimed to strategize leveraging the for-profit private sector, such as diagnostic and treatment centers, to bolster national malaria surveillance and control, advancing Bangladesh toward malaria elimination by 2030., Methods: This mixed-method study commenced with a questionnaire-based cross-sectional survey followed by selected focused group discussions (FGDs) among the participants. Three FGDs were held with the for-profit service providers so that further insights and qualitative viewpoints of them can be utilized in situation analysis. Based on the endemicity and strategic priorities, a comprehensive mapping of private for-profit facilities from the regions comprising 15 sub-districts across 8 chosen districts (7 malaria endemic districts and the rest non-endemic districts) was created. For the non-endemic zone, the sub-districts were selected based on their proximity to an area with high malaria transmission., Results: Among the 104 representative participants, majority were male (n = 92, 88.5%), had a diploma in their respective fields (n = 53, 51%) and were involved either in laboratory work (n = 49, 47.1%) or as owners/managers of health centers (n = 41, 39.4%). The selected health facilities were close to the corresponding Upazila Health Complexes (mean distance 2.8 km), but were distantly located from the designated district hospitals (mean distance 48.9 km). The main sources of RDT kits (62.3%) and anti-malarial drugs (63.2%) were local wholesale markets. A large share of the corresponding facilities neither provided malaria treatment services (81.7%) nor worked with the NMEP (93.3%)., Conclusions: This study highlights challenges and recommendations for engaging private for-profit health facilities in Bangladesh's malaria elimination efforts. The identified challenges include low-quality RDTs, staff shortages, and inadequate capacity building. Recommendations emphasize effective training, stakeholder interaction, and enhanced oversight for successful malaria control efforts., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
36. A constant contact community-based epidemiological investigation (C3EI) as part of malaria elimination demonstration project, Mandla district, Madhya Pradesh, India.
- Author
-
Singh MP, Rajvanshi H, Bharti PK, Sahu RS, Jayswar H, Nisar S, Anvikar AR, and Lal AA
- Subjects
- India epidemiology, Female, Humans, Male, Adolescent, Child, Child, Preschool, Adult, Young Adult, Infant, Middle Aged, Aged, Infant, Newborn, Incidence, Aged, 80 and over, Risk Factors, Disease Eradication statistics & numerical data, Malaria prevention & control, Malaria epidemiology
- Abstract
Background: In India, an increase in malaria cases by 21% (223,961 cases) has been reported between 2022 and 2023. Madhya Pradesh ranks 10th in malaria burden, with Mandla district selected for the Malaria Elimination Demonstration Project (MEDP) to demonstrate the feasibility of malaria elimination in a hard-to-reach, tribal-dominated, and hilly forested district. A Constant Contact Community-based Epidemiological Investigation (C3EI) was undertaken by continuous engagement with the community for real-time data collection, mapping of malaria cases, identification of risk factors, and monitoring of intervention outcomes designed to drive effective strategies for malaria elimination., Methods: The study mapped 1,143,126 individuals from 248,825 households in the year 2017 in Mandla district for constant contact surveillance. Fortnightly household visits were conducted to inquire about febrile episodes, with on-spot diagnosis and treatment. Data collection was done using the SOCH mobile application, and analysis using R., Results: The constant contact household surveillance revealed that out of 956,795 individuals, 230,780 (24.12%) unique individuals reported one or more febrile episodes, with a total of 322,577 febrile episodes and 490 malaria episodes (RDT positive). Males had a higher risk of malaria infection than females (OR = 2.62; p < 0.0001). The cumulative incidence of malaria was highest among children aged 5-15 years and pregnant women. Multiple episodes of malaria infections were more common in adults over 30 years. The incidence of malaria per 100,000 persons gradually declined from 26.13 in 2018 to 11.18 in 2020, with the highest incidence during the monsoon season., Conclusion: The C3EI presents a new strategy suitable for disease elimination programmes. Implementing C3EI-type longitudinal studies in elimination projects holds promise for generating data to expedite malaria elimination efforts because the unit of observation is a 'household'. Such a comprehensive approach allows identification in the gaps in case management for prompt interventions at the household-level., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
37. Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics.
- Author
-
Tandulje A, Varpe P, Chaugule P, Raghuvanshi RS, and Srivastava S
- Subjects
- Humans, United States, Neoplasms drug therapy, Drug Approval, Antineoplastic Agents therapeutic use, Biosimilar Pharmaceuticals therapeutic use, United States Food and Drug Administration, Biological Products therapeutic use, Biological Products economics
- Abstract
Biological oncology agents are vital in cancer care, but their exorbitant expenses present obstacles for patients, families, healthcare professionals, and insurance providers. The advent of biosimilars represents a transformative solution, offering more affordable alternatives after the expiration of biologics patents. Biosimilar agents, similar to biological agents in structure, function, safety, and immunogenicity, enhance healthcare accessibility, improve outcomes, and reduce costs. Thus, the safety of biosimilars in clinical settings is of utmost importance. This review provides a detailed overview of the United States (US) regulatory framework for biosimilars along with a comparative analysis of Food and Drug Administration (FDA) approved biosimilar products. The FDA's "Biosimilar product information" database and "FDA's Purple Book" database were used to retrieve data on approved biosimilars and reference biologicals respectively. The study compares biosimilars and their reference products, examining their physiological action, pharmacokinetics, indications, adverse reactions, and immunogenicity test results and concludes that biosimilars do not have significant variations from their reference biologic products. This analysis will offer critical insights for medical practitioners, clinicians, and patients. It empowers stakeholders to make informed decisions, assessing whether biosimilars offer an equivalent level of safety compared to their reference products. Biosimilars are endorsed as credible substitutes for originator biologics, improving accessibility and affordability in cancer care, and benefiting patients and healthcare systems., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
38. Post kala-azar dermal leishmaniasis burden at the village level in selected high visceral leishmaniasis endemic upazilas in Bangladesh.
- Author
-
Ghosh D, Sagar SK, Uddin MR, Rashid MU, Maruf S, Nath R, Islam MN, Aktaruzzaman MM, Sohel ANM, Banjara MR, Kroeger A, Aseffa A, and Mondal D
- Subjects
- Humans, Male, Female, Cross-Sectional Studies, Adult, Adolescent, Child, Bangladesh epidemiology, Young Adult, Middle Aged, Child, Preschool, Infant, Social Stigma, Patient Acceptance of Health Care, Aged, Leishmaniasis, Visceral epidemiology, Leishmaniasis, Cutaneous epidemiology, Endemic Diseases
- Abstract
Objectives: As post kala-azar Dermal Leishmaniasis (PKDL) threatens the success of the Visceral Leishmaniasis (VL) elimination initiative, we aimed to investigate the PKDL burden, including an active search for PKDL in leprosy-negative skin lesion cases. We also investigated their health-seeking behavior and perceived level of stigma., Methods: This was a cross-sectional survey among inhabitants in the VL-endemic villages of the five most VL-endemic upazilas. VL experts trained medical officers in Upazila Health Complexes (UHCs) and leprosy facilities in PKDL management. Frontline workers conducted house-to-house surveys, referring PKDL suspects to designated centers. Data analysis involved Epi Info version 7 and IBM SPSS Statistics 25., Results: Among 472,435 screened individuals, 4022 had past VL (0.85 %). Among the screened population, 82 were PKDL suspects, and 62 PKDL cases were confirmed. The overall PKDL burden was 1.3 (95 % CI: 1.0-1.7) in the 10,000 population in the endemic villages. Male predominance and macular form of PKDL were observed. Thirty-nine PKDL patients perceived stigma of different levels. Only 27 of 62 (44 %) had received PKDL treatment. Medicine's unavailability and side effects were a major reason behind treatment interruption. Active screening among 137 leprosy-negative PKDL suspects yielded 10 (7.3 %) PKDL cases., Conclusion: The existence of PKDL cases in the VL endemic areas is a concern as those are inter-epidemic reservoirs. As per the WHO roadmap, the PKDL burden must be reduced by 70 % and 100 %, respectively, by 2026 and 2030. NKEP can take the current burden of 1.3 per 10,000 people in VL endemic villages as a baseline. Integrating active case detection for PKDL in leprosy hospitals and screening centers is feasible and worth deploying nationwide., Competing Interests: Declaration of competing interest The authors have no conflicts of interest associated with the material presented in this paper., (Copyright © 2024. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
39. Organisational models for managing Public Health Emergencies of International Concern (PHEICs) in the South-East Asia Region (SEAR) nations: protocol for a systematic review.
- Author
-
Sharma R, Chauhan H, Parkash S, Verma P, Sunthlia A, Verma N, Bhawalpuria N, Kathait A, Dogra A, Garg R, Kishore J, Jain S, Bhumika TV, Gokhale RH, Desai M, Ratnoo R, and Goel A
- Subjects
- Humans, Asia, Southeastern, Research Design, Systematic Reviews as Topic, Emergencies, Models, Organizational, Public Health
- Abstract
Introduction: The current literature suggests that the frequency and complexity of public health emergencies are rising and this trend will likely continue. From 2000 to 2023, seven events have been declared as a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO). Organisational models such as the Incident Management System, Incident Response System and Incident Command System or country-specific models are essential in managing PHEIC.The review aims to achieve four key objectives. First, identify and describe the organisational models used in the South-East Asia Region (SEAR) nations defined by WHO as Bangladesh, Bhutan, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand, Timor-Leste and DPR Korea for managing PHEICs. Second, explore the indicators used to gauge the effectiveness of these models. Third, assess how these indicators impact the overall success of organisational models. Finally, the review will delve into the implementation aspects gaining a deeper understanding of how the organisational models are put into practice to manage PHEICs in the SEAR region., Methods and Analysis: Following Preferred Reporting Items for Systematic review and Meta-Analysis Protocols guidelines, a qualitative evidence synthesis will be conducted. A defined search strategy will be employed to conduct a comprehensive literature search of the following academic databases: PubMed (MEDLINE), Excerpta Medica Database, Cochrane CENTRAL, Cumulative Index to Nursing and Allied Health Literature, WHO Library Database, US Centers for Disease Control and Prevention (CDC), CDC's Morbidity and Mortality Weekly Report and Web of Science; as well as non-academic databases including Google Scholar, Evidence Aid, Epistemonikos, Shodhganga and ResearchGate. This review will employ the SPIDER-D tool for searching qualitative studies. Two reviewers will check the quality of included studies and will be appraised using standard critical appraisal tools. In case of any difference between the two reviewers, a third reviewer will take the decision., Ethics and Dissemination: No ethical approval is required. Results will be published in a peer-reviewed journal and disseminated through a workshop for stakeholders and policymakers., Prospero Registration Number: CRD42023394418., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
40. Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery.
- Author
-
Ali M, Longet S, Neale I, Rongkard P, Chowdhury FUH, Hill J, Brown A, Laidlaw S, Tipton T, Hoque A, Hassan N, Hackstein CP, Adele S, Akther HD, Abraham P, Paul S, Rahman MM, Alam MM, Parvin S, Mollah FH, Hoque MM, Moore SC, Biswas SK, Turtle L, de Silva TI, Ogbe A, Frater J, Barnes E, Tomic A, Carroll MW, Klenerman P, Kronsteiner B, Chowdhury FR, and Dunachie SJ
- Subjects
- Humans, Male, Female, Adult, Cross-Sectional Studies, Middle Aged, CD8-Positive T-Lymphocytes immunology, T-Lymphocytes immunology, Bangladesh, Immunity, Cellular, COVID-19 immunology, COVID-19 complications, Obesity immunology, Obesity complications, SARS-CoV-2 immunology, Antibodies, Viral blood, Antibodies, Viral immunology, Diabetes Mellitus, Type 2 immunology, Antibodies, Neutralizing immunology, Antibodies, Neutralizing blood
- Abstract
Objective: Obesity and type 2 diabetes (DM) are risk factors for severe coronavirus disease 2019 (COVID-19) outcomes, which disproportionately affect South Asian populations. This study aims to investigate the humoral and cellular immune responses to SARS-CoV-2 in adult COVID-19 survivors with overweight/obesity (Ov/Ob, BMI ≥ 23 kg/m2) and DM in Bangladesh., Methods: In this cross-sectional study, SARS-CoV-2-specific antibody and T-cell responses were investigated in 63 healthy and 75 PCR-confirmed COVID-19 recovered individuals in Bangladesh, during the pre-vaccination first wave of the COVID-19 pandemic in 2020., Results: In COVID-19 survivors, SARS-CoV-2 infection induced robust antibody and T-cell responses, which correlated with disease severity. After adjusting for age, sex, DM status, disease severity, and time since onset of symptoms, Ov/Ob was associated with decreased neutralizing antibody titers, and increased SARS-CoV-2 spike-specific IFN-γ response along with increased proliferation and IL-2 production by CD8 + T cells. In contrast, DM was not associated with SARS-CoV-2-specific antibody and T-cell responses after adjustment for obesity and other confounders., Conclusion: Ov/Ob is associated with lower neutralizing antibody levels and higher T-cell responses to SARS-CoV-2 post-COVID-19 recovery, while antibody or T-cell responses remain unaltered in DM., (© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Immunology.)
- Published
- 2024
- Full Text
- View/download PDF
41. Quality of Life, Coping Strategies, and Psychosocial Support Status of Caregivers Having Children With Neurodevelopmental Disabilities: A Cross-Sectional Study From Bangladesh.
- Author
-
Tasnim A, Salwa M, Islam S, Khan MMH, Islam MT, Ratan ZA, Towhid MII, Al Mamun MA, Amin MR, and Haque MA
- Abstract
Background Although caregiving is considered a normal phenomenon for parents, delivering care to a child with neurodevelopmental disabilities can be taxing and disastrously impact parents' quality of life (QoL). This study explored the relationship between QoL, coping strategies, and psychosocial support status of caregivers of children with neurodevelopmental disabilities. Methodology This cross-sectional study included 906 caregivers of children having neurodevelopmental disabilities utilizing the World Health Organization Quality of Life Brief and Perceived Stress Scale. A tailored questionnaire gauged coping strategies and psychosocial support. Linear regression was used to identify significant contributors. Results Most caregivers (78.8%) experienced a moderate level of stress, and their QoL scores were 14.4 (SD = 2.5) for physical health, 12.0 (SD = 2.4) for psychological health, 14.6 (SD = 1.9) for social relationships, and 12.1 (SD = 2.1) for the environment. Mothers had the lowest QoL of all caregivers. Negative influences on QoL encompassed caregiver and child age, perceived stress, and lower socioeconomic status. A higher coping score positively predicted a high health-related QoL score. Gender differences were observed in psychosocial support sources. Conclusions The study underscores the need for policymaking considering findings to develop psychosocial intervention programs for enhancing the QoL of caregivers of children with neurodevelopmental disabilities., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Bangabandhu Sheikh Mujib Medical University issued approval BSMMU/2019/6025. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Tasnim et al.)
- Published
- 2024
- Full Text
- View/download PDF
42. Clinical and biochemical responses to treatment of uncomplicated severe acute malnutrition: a multicenter observational cohort from the OptiDiag study.
- Author
-
Deng L, Argaw A, Guesdon B, Freemark M, Roberfroid D, Kemokai IA, Mostak MR, Alim MA, Khan MAH, Muehlbauer M, Khan MMST, Bawo L, Dunbar NK, Taylor CH, Fouillet H, Huneau JF, Lachat C, Kolsteren P, and Dailey-Chwalibóg T
- Subjects
- Humans, Male, Female, Infant, Child, Preschool, Bangladesh epidemiology, Burkina Faso, Cohort Studies, Nutritional Status, Liberia, Leptin blood, Body Weight, Severe Acute Malnutrition therapy
- Abstract
Background: Severe acute malnutrition (SAM) can be diagnosed using weight-for-height Z-score (WHZ) and/or mid-upper arm circumference (MUAC). Although some favor using MUAC alone, valuing its presumed ability to identify children at greatest need for nutritional care, the functional severity and physiological responses to treatment in children with varying deficits in WHZ and MUAC remain inadequately characterized., Objective: We aimed to compare clinical and biochemical responses to treatment in children with 1) both low MUAC and low WHZ, 2) low MUAC-only, and 3) low WHZ-only., Methods: A multicenter, observational cohort study was conducted in children aged 6-59 mo with nonedematous, uncomplicated SAM in Bangladesh, Burkina Faso, and Liberia. Anthropometric measurements and critical indicators were collected 3 times during treatment; metrics included clinical status, nutritional status, viability, and serum leptin, a biomarker of mortality risk in SAM., Results: Children with combined MUAC and WHZ deficits had greater increases in leptin levels during treatment than those with low MUAC alone, showing a 34.4% greater increase on the second visit (95% confidence interval [CI]: 7.6%, 43.6%; P = 0.02) and a 34.3% greater increase on the third visit (95% CI: 13.2%, 50.3%; P = 0.01). Similarly, weight gain velocity was higher by 1.56 g/kg/d in the combined deficit group (95% CI: 0.38, 2.75; P = 0.03) compared with children with low MUAC-only. Children with combined deficits had higher rates of iron deficiency and wasting while those with low WHZ alone and combined deficits had higher rates of tachypnea and pneumonia during treatment., Conclusions: Given the comparable treatment responses of children with low WHZ alone and those with low MUAC alone, and the greater vulnerability at admission and during treatment in those with combined deficits, our findings support retaining WHZ as an independent diagnostic and admission criterion of SAM, alongside MUAC. This trial was registered at www., Clinicaltrials: gov/study/NCT03400930 as NCT03400930., (Copyright © 2024 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
43. The Impact of Saline Water on Women's Health in the Coastal Region of Bangladesh: Special Attention on Menstrual Hygiene Practices.
- Author
-
Sinha S, Ahmad R, Chowdhury K, Ferdaus F, Banik S, Mehta M, Kumar S, Haq MA, and Haque M
- Abstract
Introduction Salinity intrusion is the most common global concern along coastlines, but it can happen inland also. The lack of freshwater is the primary issue affecting the coastal areas. Many health problems are prevalent among the inhabitants due to their frequent use of salted water. The health of women living along the coastline is getting progressively compromised due to salinity intrusion. Objectives The study aims to determine menstrual health practices and other health problems faced by women in the coastal region of Bangladesh. Methods The study was conducted using a survey research design from May 2023 to October 2023 on rural women aged 18 to 45 years, who lived in the Bangladeshi village of Koyra Upazila in the Khulna district. The sample size of the study was 101. Open- and closed-ended questions from a planned interview schedule were used to gather primary data. Additional information from appropriate sources, e.g., newspapers, publications, and books, was utilized to enhance the comprehensiveness of statistical analysis and support rationality. A p-value of 0.05 was considered significant. Statistical analysis was performed using STATA version 15 (StataCorp LLC, College Station, TX). Results Menstrual hygiene practices showed a higher prevalence of using fabric rags and reusing them after rinsing them in salt water (72.3%) than sanitary pads (25.7%). It was observed that the risk of diarrhea among tubewell water and rainwater users was significantly lowered by 0.25 times (95% CI = 0.06, 0.99; p = 0.049) and 0.06 times (95% CI = 0.01, 0.43; p = 0.005), respectively, compared to pond water users. Conclusion Salinity has a significant impact on the livelihoods and health of coastal women. The village women are unaware of the health risks of excessive saline water use. Establishing an adequate supply of freshwater reservoirs for the entire community throughout the year is an alternative for women to use as a source of water for hygiene necessities., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Institutional Review Board of the National Institute of Cancer Research & Hospital (NICRH), Dhaka, Bangladesh issued approval NICRH/IRB/2023/18; Dated: 15/03/2023. In addition, the participants received a thorough explanation from the researchers regarding their future publication plans and study objectives. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Sinha et al.)
- Published
- 2024
- Full Text
- View/download PDF
44. Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial.
- Author
-
Abrar A, Hu X, Akhtar J, Jubayer S, Noor Nabi Sayem M, Sultana S, Al Mamun MA, Bhuiyan MR, Malik F, Amin MR, Alim A, Gupta R, Zhao D, Farrell M, Banigbe B, Matsushita K, Burka D, Appel L, Moran AE, and Choudhury SR
- Subjects
- Humans, Bangladesh epidemiology, Female, Male, Middle Aged, Antihypertensive Agents therapeutic use, Blood Pressure physiology, Adult, Treatment Outcome, Aged, Hypertension physiopathology, Hypertension epidemiology, Hypertension therapy, World Health Organization
- Abstract
Background: The World Health Organization (WHO) promotes the HEARTS technical package for improving hypertension control worldwide, but its effectiveness has not been rigorously evaluated., Objective: To compare hypertension outcomes in clinics implementing HEARTS versus clinics continuing usual hypertension care in rural Bangladesh., Methods: A matched-pair cluster quasi-experimental trial in Upazila Health Complexes (UHCs; primary healthcare facilities) was conducted in rural Bangladesh. A total of 3935 patients (mean age 52.3 years, 70.5% female) with uncontrolled hypertension (blood pressure (BP) ≥140/90 mm Hg regardless of treatment history) were enrolled: 1950 patients from 7 HEARTS UHCs and 1985 patients from 7 matched usual care UHCs. The primary outcome was systolic BP at 6 months measured at the patient's home; secondary outcomes were diastolic BP, hypertension control rate (<140/90 mm Hg) and loss to follow-up. Multivariable mixed-effects linear and Poisson models were conducted., Results: Baseline mean systolic BP was 158.4 mm Hg in the intervention group and 158.8 mm Hg in the usual care group. At 6 months, 95.5% of participants completed follow-up. Compared with usual care, the intervention significantly lowered systolic BP (-23.7 mm Hg vs -20.0 mm Hg; net difference -3.7 mm Hg (95% CI -5.1 to -2.2)) and diastolic BP (-10.2 mm Hg vs -8.3 mm Hg; net difference -1.9 mm Hg (95% CI -2.7 to -1.1)) and improved hypertension control (62.0% vs 49.7%, net difference 12.3% (95% CI 9.0 to 16.8)). Rate of missed clinic visits was lower in the intervention group (8.8% vs 39.3%, p<0.001)., Conclusions: After WHO-HEARTS package implementation in rural Bangladesh, BP was lowered and hypertension control improved significantly compared with usual care., Trial Registration Number: NCT04992039., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
45. Job satisfaction and performance among employed Bangladeshi women working from home during COVID-19 pandemic: A cross-sectional study.
- Author
-
Jannat H, Saif-Ur-Rahman KM, Noor IN, and Begum A
- Abstract
Background and Aims: The emergence of the COVID-19 pandemic led to the adoption of telework modalities by individuals in Bangladesh. The study's objective was to determine the job satisfaction and performance level of employed Bangladeshi women working from home during the COVID-19 pandemic lockdown., Methods: A cross-sectional study was conducted among women employees of different professions in Dhaka city. The Minnesota Satisfaction Questionnaire (MSQ) was used to measure job satisfaction. Work arrangement satisfaction and self-reported performance were measured by two separate subscales which contain five items each. Responses from 118 employed women were analyzed using descriptive statistics, Pearson Chi-square tests, Independent t -tests, one-way analysis of variance, and Pearson Correlation tests through the Statistical Package for Social Science (SPSS), version 26., Results: The findings indicated that 51.7% of women reported a high degree of satisfaction on the MSQ scale; 61.9% expressed high satisfaction with their work arrangements at home and 66.9% reported a high level of performance. Job satisfaction was significantly associated with the number of children and the number of family members. A positive association was found between job satisfaction and total working experience and work arrangements. Work performance was strongly associated with higher educational qualifications. A statistically significant association between job satisfaction and performance was revealed., Conclusions: The findings from this study indicated a high degree of job satisfaction and a high level of performance found in women employees who worked from home during the COVID-19 pandemic. These findings encourage organizations to foster more policies for telework alternatives for employed women to help them keep a balance between work responsibilities and household chores., Competing Interests: The authors declare no conflict of interest., (© 2024 The Author(s). Health Science Reports published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
46. Distribution and disparities of healthy lifestyles and noncommunicable diseases risk factors between men and women aged 20-59 years in Bangladesh: Evidence from a nationwide survey.
- Author
-
Hossain MM, Roy A, Hanif AAM, Akter F, Hasan M, Khan MSA, Shamim AA, Hossaine M, Ullah MA, Rahman SMM, Bulbul MI, Mitra DK, and Mridha MK
- Abstract
Background: Noncommunicable diseases (NCDs) are public health threats globally and recognized impediments to socioeconomic development. This study aimed to identify the prevalence and clustering of NCDs risk factors among Bangladeshi men and women aged 20-59 years using nationally representative data., Methods: This study was conducted in 82 rural, nonslum urban, and slum clusters across all eight administrative divisions of Bangladesh using multistage cluster sampling. A total of 4917 men and 4905 women aged 20-59 years were included in the study. Descriptive analyses were performed to report the prevalence and distribution of behavioral and clinical risk factors. Multivariable binary logistic regression was performed to identify factors associated with the coexistence of three or more NCD risk factors., Results: The prevalence of tobacco use (any form), insufficient physical activity, inadequate fruit and vegetable consumption, overweight and obesity, and central obesity were 38.3%, 13.6%, 87.1%, 42.3%, and 36.0%, respectively. Furthermore, 21.9% and 4.9% participants had hypertension and self-reported diabetes, respectively. Regarding the clustering of risk factors, 37.1% men and 50.8% women had at least three NCD risk factors. Only 3.0% men and 1.8% women reported no NCD risk factors. Age, place of residence, education, and wealth status were associated with the presence of at least three risk factors for both sexes., Conclusion: Since a large proportion of Bangladeshi 20-59 years old population had multiple risk factors, population-based programs with multisectoral approaches are essential to reduce NCDs among Bangladeshi women and men., Competing Interests: The authors declare no conflict of interest., (© 2024 The Author(s). Chronic Diseases and Translational Medicine published by John Wiley & Sons Ltd on behalf of Chinese Medical Association.)
- Published
- 2024
- Full Text
- View/download PDF
47. Colorectal Cancer Detection during a Screening Awareness Campaign in a High-Risk Region in Oman.
- Author
-
Al Mutaani J, Al Hasani B, Al Hattali S, Al Oraimi M, Al Alawi N, Kumar S, Al Sadi K, Al Alawi S, Al Harbi M, Al Faraji A, Al Rajhi A, Al Jaffari M, Al Jaffari S, Al Alawi M, Al Suri M, Al Satmi F, Al Saadi M, Al Rottali B, Al Wihabi F, Hmissa S, Ouahchi I, and Missaoui N
- Subjects
- Humans, Male, Middle Aged, Female, Oman epidemiology, Adult, Risk Factors, Mass Screening methods, Health Knowledge, Attitudes, Practice, Prognosis, Aged, Follow-Up Studies, Surveys and Questionnaires, Health Promotion methods, Colorectal Neoplasms diagnosis, Colorectal Neoplasms epidemiology, Colorectal Neoplasms prevention & control, Early Detection of Cancer methods, Early Detection of Cancer statistics & numerical data, Occult Blood, Colonoscopy statistics & numerical data
- Abstract
Introduction: Colorectal cancer (CRC) constitutes the third most frequently diagnosed cancer in Oman. This study report the result of a community based screening campaign to promote the early detection and explore the associated risk factors of CRC amongst Omani population., Methods: We launched a colorectal cancer awareness campaign in Oman's South Ash Sharqiyah Governorate between January and March, 2023. We conducted a stratified random study including 688 adult Omani participants aged over 40 years old. Local Health Centers collected the questionnaire forms. Fecal occult blood tests (FOBTs) were carried out at Local Health Centers; while medical professionals performed the colonoscopy examination in Sur University Hospital., Results: Overall, the screening response rate was 68.8%. The data indicated that 8.1% of the total sample yielded positive FOBTs; of whom, 85.7% were aged 40-59 years old and 67.9% were obese or overweight. Abnormal colonoscopy was reported in 7 participants. One participant had a confirmed CRC of stage I., Conclusion: Screening and early detection campaign can have effect and increase the rate of early detection among population in Oman.
- Published
- 2024
- Full Text
- View/download PDF
48. In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges.
- Author
-
Rahman MM, Wells G, Rantala JK, Helleday T, Muthana M, and Danson SJ
- Subjects
- Humans, Tumor Microenvironment immunology, Animals, Drug Screening Assays, Antitumor methods, Precision Medicine methods, Neoplasms immunology, Neoplasms therapy, Neoplasms drug therapy, Immunotherapy methods
- Abstract
Introduction: Immunotherapies have revolutionized cancer treatment, but often fail to produce desirable therapeutic outcomes in all patients. Due to the inter-patient heterogeneity and complexity of the tumor microenvironment, personalized treatment approaches are gaining demand. Researchers have long been using a range of in-vitro assays including 2D models, organoid co-cultures, and cancer-on-a-chip platforms for cancer drug screening. A comparative analysis of these assays with their suitability, high-throughput capacity, and clinical translatability is required for optimal translational use., Areas Covered: The review summarized in-vitro platforms with their comparative advantages and limitations including construction strategies, and translational potential for immuno-oncology drug efficacy assessment. We also discussed end-point analysis strategies so that researchers can contextualize their usefulness and optimally design experiments for personalized immunotherapy efficacy prediction., Expert Opinion: Researchers developed several in-vitro platforms that can provide information on personalized immunotherapy efficacy from different angles. Image-based assays are undoubtedly more suitable to gather a wide range of information including cellular morphology and phenotypical behaviors but need significant improvement to overcome issues including background noise, sample preparation difficulty, and long duration of experiment. More studies and clinical trials are needed to resolve these issues and validate the assays before they can be used in real-life scenarios.
- Published
- 2024
- Full Text
- View/download PDF
49. Rabies control in Bangladesh and prediction of human rabies cases by 2030: a One Health approach.
- Author
-
Ghosh S, Hasan MN, Nath ND, Haider N, Jones DH, Islam MK, Rahaman MM, Mursalin HS, Mahmud N, Kamruzzaman M, Rabby MF, Kar S, Ullah SM, Ali Shah MR, Jahan AA, Rana MS, Chowdhury S, Uddin MJ, Sunil TS, Ahmed BN, Siddiqui UR, Kaisar SMG, and Islam MN
- Abstract
Background: Bangladesh is making progress toward achieving zero dog-mediated rabies deaths by 2030, a global goal set in 2015., Methods: Drawing from multiple datasets, including patient immunisation record books and mass dog vaccination (MDV) databases, we conducted a comprehensive analysis between 2011 and 2023 to understand the effectiveness of rabies control programmes and predict human rabies cases in Bangladesh by 2030 using time-series forecasting models. We also compared rabies virus sequences from GenBank in Bangladesh and other South Asian countries., Findings: The estimated dog population in Bangladesh was determined to be 1,668,140, with an average dog population density of 12.83 dogs/km
2 (95% CI 11.14-14.53) and a human-to-dog ratio of 86.70 (95% CI 76.60-96.80). The MDV campaign has led to the vaccination of an average of 21,295 dogs (95% CI 18,654-23,935) per district annually out of an estimated 26,065 dogs (95% CI 22,898-29,230). A declining trend in predicted and observed human rabies cases has been identified, suggesting that Bangladesh is poised to make substantial progress towards achieving the 'Zero by 30' goal, provided the current trajectory continues. The phylogenetic analysis shows that rabies viruses in Bangladesh belong to the Arctic-like-1 group, which differs from those in Bhutan despite sharing a common ancestor., Interpretation: Bangladesh's One Health approach demonstrated that an increase in MDV and anti-rabies vaccine (ARV) resulted in a decline in the relative risk of human rabies cases, indicating that eliminating dog-mediated human rabies could be achievable., Funding: The study was supported by the Communicable Disease Control (CDC) Division of the Directorate General of Health Services (DGHS) of the People's Republic of Bangladesh., Competing Interests: The authors declared that they have no competing interests., (© 2024 The Authors.)- Published
- 2024
- Full Text
- View/download PDF
50. Community perspective and healthcare assessment in malaria endemic states of India: a cross-sectional study protocol.
- Author
-
B M S, H C V, Singhal R, Singh K, N SN, Tripathi PK, Singh P, Eapen A, Singh SP, Sinha DP, Malla WA, Gupta SK, Yadav CP, Singh P, Aggarwal CS, P Choudhary V, Sharma R, Jain T, Sharma A, Anvikar AR, Goel A, and Rahi M
- Subjects
- Humans, India epidemiology, Cross-Sectional Studies, Research Design, Antimalarials therapeutic use, Health Knowledge, Attitudes, Practice, Delivery of Health Care, Malaria epidemiology, Malaria prevention & control, Endemic Diseases
- Abstract
Introduction: India's contribution to the malaria burden was highest in South-East Asia Region in 2021, accounting for 79% of the estimated malaria cases and 83% of malaria-related deaths. Intensified Malaria Control Programme supported by Global Funds to Fight against AIDS, Tuberculosis and Malaria has deployed crucial interventions to reduce the overall burden of malaria in India. Evaluation of utilisation of malaria elimination interventions by the community and assessment of the healthcare system is underway in eleven high malaria endemic states in India. Health system preparedness for malaria elimination, logistics, and supply chain management of diagnostic kits and anti-malarial drugs in addition to the knowledge, attitude and practice of the healthcare workers is also being assessed., Methods and Analysis: The study is being undertaken in 11 malaria endemic states with a variable annual parasite incidence of malaria. In total, 47 districts (administrative unit of malaria control operations) covering 37 976 households are to be interviewed and assessed. We present here the protocol following which the study is being undertaken at the behest and approval of Ministry of Health and Family Welfare in India., Ethics and Dissemination: No patients were involved in the study. Study findings will be shared with Institutional ethics board of National Institute for Malaria Research New Delhi (NIMR) in a timely, comprehensive, accurate, unbiased, unambiguous and transparent manner and to the National Vector-borne Disease (Malaria) Control Programme officers and the Community public who participated. Important findings will be communicated through community outreach meetings which are existing in the Health system. Results will be informed to study participants via local fieldwork supervised by District Malaria Officers. Also findings will be published in reputed journals based on Indian Council of Medical Research (ICMR) publication policy.The ICMR-NIMR ethics committee approved the study via letter No. NIMR/ECM/2023/Feb/14 dated 24 April 2023 for version 5. All standard ethical practices will be followed., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.